13
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Literature Alerts

Pages 665-683 | Published online: 26 Jun 2009

LITERATURE ALERTS

  • 3(3) factorial design-based optimization of the formulation of nitrofurantoin microcapsules. KARASULA, H. Y., ERTAN, G., and GUNERI, T., Pharm. World. Sci., 1996, 18 (1), 20–25.
  • 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics. AKBUGA, J., and BERGISADI, N.,.7. Microencapsul., 1966, 13 (2), 161–168.
  • A rapid qualitative method to assess in vitro immunobarrier competence of pancreatic islets containing alginate/polyaminoacidic microcapsules. CALAFIORE, R., BASTA, G., SARCHIELLI, P., LUCA, G., TORTOIOLI, C., and BRuNETT1, P., Acta Diabetol., 1996, 33 (2), 150–153.
  • A synthetic peptide representing residues 7 to 21 of human luteinizing hormone beta-subunit binds calcium, facilitates calcium uptake by liposomes and possesses sequence similarity to calcium-binding domains of calmodulin. GRASSO, P., Regul. Pept., 1996, 65 (2), 109–114.
  • A comparison of the use of two immunomagnetic microspheres for secondary purification of pancreatic islets. DAVIES, J. E., WINOTO, M. S., ULRICHS, K., JAMES, R. F., and ROBERTSON, G. S., Transplantation, 1996, 62 (9), 1301–1306.
  • A method to detect leakage of DNA intercalators through liposome membranes. SILVANDER, M., and EDWARDS, K., Anal. Biochem., 1996, 242 (1), 40–44.
  • A model for dose estimation in therapy of liver with intraarterial microspheres. ZAVGORODNI, S. F., Phys. Med. Biol., 1996, 41(11), 2463–2480.
  • A monitoring system for energy transduction by bacteriorhodopsin liposomes. HENDLER, R. W., MUKHOPADHYAY, A. K., SMITH, P. D., and CASCIO, H. E.,.7. Biochem. Biophys. Methods, 1996, 33 (2), 89–104.
  • A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in VIVO. STEPHEN, D. J., YANG, Z. Y., SAN, H., SIMARI, R. D., WHEELER, C. J., FELGNER, P. L., GORDON, D., NABEL, G. J., and NABEL, E. G., Hum. Gene. Ther., 1996, 7 (15), 1803–1812.
  • A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects. Jmul, Y., HORI, S., MINAMITANI, K., HASHIMOTO, T., YOSHIMUFtA, H., NOMURA, N., ISHIDA, T., FUKUDA, H., TOMODA, K., and NAKAMURA, H., Nippon Igaku Hoshasen Gakkai Zasshi, 1996, 56(1), 19–24.
  • A newly developed three-layer agarose microcapsule for a promising biohybrid artificial pancreas: rat to mouse xenotransplantation. TUN, T., INOUE, K., HAYASHI, H., AUNG, T., Gu, Y. J., Doi, R., KAJI, H., ECHIGO, Y., WANG, W. J., SETOYAMA, H., IMAMURA, M., MAETANI, S., MORIKAWA, N., IWATA, H., and IKADA, Y., Cell transplant, 1966, 5 (5 Suppl 1), S59–63.
  • A simple structural model for the polymer microsphere stabilized by the poly(ethylene oxide) macromonomers grafted on its surface. Wu, C., AKASHI, M., and CHEN, M. Q., Macromolecules, 1997, 30 (7), 2187–2189.
  • A study of water adsorption on ground glass microspheres of different chemical compositions. STETSENKO, V. Y., YUSFICHENKO, V. V., and SHAKHNOVSKAYA, 0. L., Glass Phys. Chem. (Transl. of Fiz. Khim. Stekla), 1996, 22(6), 555–559.
  • A study on chemotherapy for esophageal cancer using peplomycin-loaded microspheres. An experimental study. OHSAWA, M., HAMABE, Y., IKUTA, H., and SAITOH, Y., Kobe Daigaku Igakubu Kiyo, 1996, 57 (1/2), 11–19.
  • Adjuvant activity of linear aliphatic polyester and branched aliphatic oligoester microspheres. HAMPL., J., DITTRICH, M., FRANZ, J., RESCHOVA, S., STEPANEK, J., ha. .7. Pharm., 1996, 144(1), 107–114.
  • Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. GUPTA, R. K., VARANELLI, C. L., GRIFFIN, P., WALLACH, D. F., and SIBER, G. R., Vaccine, 1996, 14 (3), 219–225.
  • Adsorption of BSA on highly carboxylated microspheres—quantitative effects of surface functional groups and interaction forces. YOON, J. Y., PARK, H. Y., KIM, J. H., and Km, W. S.,.7. Colloid Interface Sci., 1996, 182 (2), 617.
  • Agent targeting by means of the chemically or physically directed, fusogenic liposomes. CEVC, G., y. Liposome Res., 1996, 6 (4), 643–663.
  • Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione. SUNTRES, Z. E., and SHEK, P. N., Biochem. Pharmacol., 1996, 52 (10), 1515–1520.
  • Alpha-Tocopherol liposomes alleviate LPS-induced hepatotoxicities. SUNTRES, Z. E., and SHEK, P. N., J. Endotoxin Res., 1996, 3 (6), 505–512.
  • Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats. MOGHIMI, S. M., and PATEL, H. M., Biochem. Biophys. Acta., 1996, 1285 (1), 56–64.
  • An experimental study on the chemotherapy of esophageal cancer with cisplatin-loaded microspheres. SHIFtAISHI, T., HAMABE, Y., IKUTA, H., and SAITOH, Y., Kobe Daigaku Igakubu Kiyo, 1996, 57 (1/2), 99–106.
  • Analysis of microcapsule resin using x-ray photoelectron spectrometry. KOBAYASHI, N., IsmouRo, M., and ENDO, K., y. Surf Anal, 1996, 2 (2), 194–202.
  • Anti-pseudomonal activity of collagen sponge with liposomal polymyxin B. TRAFNY, E. A., GRZYBOWSKI, J., OLSZOWSKA, G. M., ANTOS, M., STRUZYNA, J., Pharmacol. Res., 1966, 33 (1), 63–65.
  • Antinociceptive effect of bupivacaine encapsulated in poly(DL)-lactide-co-glycolide micro-spheres in the acute inflammatory pain model of carrageenin-injected rats. FLETCHER, D. LE CORRE, P., GUILBAUD, G., and LE VERGE, R., Anesth. Analg. (Baltimore), 1997, 84(1), 90–94.
  • Antioxidant actions of beta-carotene in liposomal and microsomal membranes: role of carotenoid-membrane incorporation and alpha-tocopherol. LIEBLER, D. C., STRArroN, S. P., and KAYSEN, K. L., Arch. Biochem. Biophys., 1997, 338 (2), 244–250.
  • Antiproliferative activity of a liposomal delivery system of mitoxantrone on rabbit subcon-junctival fibroblasts in an ex-vivo model. MAIGNEN, F., TILLEUL, P., BILLARDON, C., XU, V. 0. W. Y., PELAPRAT, D., ELENA, P. P., DENIS, P., and ROSTENE, W., J. Ocul. Pharmacol. Ther., 1966, 12 (3), 289–298.
  • Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma. JAMEELA, S. R., LATHA, P. G., SUBRAMONIAM, A., and JAYAKRISHNAN, A., J. Pharm. Pharmacol., 1996, 48 (7), 685–688.
  • Application of a novel B cell line MIN6 to a mesh-reinforced polyvinyl alcohol hydrogel tube and three-layer agarose microcapsules: an in vitro study. HAYASHI, H., INouE, K., AUNG, T., TUN, T., YUANJUN, G., WENJING, W., SHINOHARA, S., KAP, H., Doi, R., SETOYAMA, H., KATO, M, IMAMURA, M, MAETANI, S, MORIKAWA, N, IWATA, H., IKADA, Y., and MIYAZAKI, J., Cell Transplant, 1996, 5 (5 Suppl 1), S65–69.
  • Application of alginate gel as a vehicle for liposomes. I. Factors affecting the loading of drug-containing liposomes and drug release. TAKAGI, I., SHIMIZU, H., and YOTSUYANAGI, T., Chem. Pharm. Bull., (Tokyo), 1996, 44 (10), 1941–1947.
  • Application of antibody and fluorophore-derivatized liposomes to heterogeneous immunoas-says for d-dimer. SINGH, A. K., KILPATRICK, P. K., and CARBONELL, R. G., Biotechnol. Frog., 1996, 12 (2), 272–280.
  • Application of classical experimental design for the development of theophylline microspheres. GotiEL, M. C., JAN1, G. K., AMIN, A. F., PATEL, K. V., and GUPTA, S. V., J. Controlled Release, 1997, 45 (3), 265–271.
  • Application of microcapsulation technique for food. OSAWA, H., Shoku no Kagaku, 1996, 226, 42–50.
  • Aqueous-based microencapsulation enhances virus-specific humoral immune responses in mice after parenteral inoculation. MOSER, C. A., SPEAKER, T. J., BERLIN, J. A., and OFFIT, P. A., Vaccine, 1996, 14 (13), 1235–1238.
  • Aspects of the mechanics of lobed liposomes. PAMPLONA, D. C., CALLADINE, C. R., J. Biomech. Eng., 1996, 118 (4), 482–488.
  • Assay of phosphatidylcholine in liposome suspnesions by inductively coupled plasma atomic emission spectrometry with ultrasonic nebulizer. KAMIDATE, T., SUITA, T., and WATANABE, H., Anal. Biochem., 1996, 241 (2), 264–266.
  • Assembly properties of Triton X-100/phosphatidylcholine aggregates during liposome solubilization. DE LA MAZA, A., and PARRA, J. L., Colloid Polym. Sci., 1996, 274 (9), 866-874. Basic study on functional liposomes and their application. OKU, N., Cell Mol. Biol. Lett., 1996, 1 (4), 417–427.
  • Beneficial effect of nebracetam on energy metabolism after microsphere-induced embolism in rat brain. TAKEO, S., MIYAKE, K., TANONAKA, K., TAKAGI, N., TAKAGI, K., KISHIMOTO, K., SUZUKI, M., KATSURAGI, A., GOTO, M., and OSHIKAWA, S., Arch. Int. Pharmacodyn. Ther., 1996, 331 (3), 232–245.
  • Binding of daidzein to liposomes. LEHTONEN, J. Y., ADLERCREUTZ, H., and KINNUNEN, P. K., Biochim. Biophys. Acta, 1996, 1285 (1), 91–100.
  • Bioavailability of microencapsulated ferrous sulfate in fluid milk studies in human beings. GOTELLI, C. A., GOTELLI, M. J., BOCCI°, J. R., ZUBILLAGA, M. B., CARO, R. A., GARCIA DEL Rio, H., and WEILL, R., Acta Physiol., Pharmacol. Ther. Latinoam., 1996, 46 (4), 239–245.
  • Bioavailability and stability of microencapsulated ferrous sulfate in fluid milk: studies in mice. Bocci°, J. R., ZUBILLAGA, M. B., CARO, R. A., GOTELLI, C. A., GOTELLI, M. J., WEILL, R., y. Nutr. Sci. Vitaminol. (Tokyo), 1996, 42 (3), 233–239.
  • Biodegradable microspheres as a delivery system for rismorelin porcine, a porcine-growth-hormone-releasing-hormone. THOMPSON, W. W., ANDERSON, D. B., HEIMAN, M. L., J. Controlled Release, 1997, 43 (1), 9–22.
  • Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes. SACHSE, A., LEIKE, J. U., SCHNEIDER, T., WAGNER, S. E., ROEBLING, G. L., KRAUSE, W., and BRANDL, M., Invest. Radial., 1997, 32 (1), 44–50.
  • Blood-brain-barrier transport of lipid microspheres containing clinprost, a prostaglandin 12 analog. MINAGAWA, T., SAKANAKA, K., INABA, S. I., SAI, Y., TAMAI, I., SUWA, T., and TSUJI, A., J. Pharm. Pharmacol., 1996, 48 (10) 1016–1022.
  • Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-mela-noma-bearing mice. RESZKA, R., BECK, P., FICHTNER, I., HENTSCHEL, M., RICHTER, J., and KREUTER, J., J. Pharmacol.. Exp. Ther., 1997, 280 (1), 232–237.
  • Bovine serum albumin release from poly(alpha-hydroxy acid) microspheres: effects of polymer molecular weight and surface properties. BOURY, F., MARCHAIS, H., PROUST, J. E., and BENOIT, J. P., J. Controlled Release, 1997, 45 (1), 75–86.
  • Ca2 + -induced interaction of acidic liposomes with erythrocyte membrane: I. Role of liposome phospholipid composition in the interaction with hemolyzed erythrocyte ghosts. HERNANDEZ, J. E. I., VLADIMIROV, Y. A., and Hui, S. W., Phys. Chem. Biol. Med., 1995, 2 (2), 75–81.
  • Ca2 + -induced interaction of acidic liposomes with erythrocyte membrane: II. The role of the erythrocyte membrane. HERNANDEZ, J. E. I., VLADIMIROV, Y. A., and Hui, S. W., Phys. Chem. Biol. Med., 1995, 2 (2), 83–86.
  • Cationic liposomes enhanced firefly bioluminescent assay of adenosine 5 Ctriphosphate disodium salt. KAMIDATE, T., KINKOU, T., and WATANABE, H., Anal. Biochem., 1997, 244 (1), 62–66.
  • Cellular uptake and localization of liposomal-methylphosphonate oligodeoxynucleotides. TAR', A. M., ANDREEF, M., KLEINE, H. D., and LOPEZ, B. G., y. Mol. Med. (Berlin), 1996, 74 (10), 623–628.
  • Cellulose acetate trimellitate ethylcellulose blends for non-steroidal anti-inflammatory drug (NSAID) microspheres. GIUNCHEDI, P., TORRRE, M. L., MAGGI, L., CONTI, B., and CONTE, U., y. Microencapsul., 1996, 13 (1), 89–98.
  • Characteristics of DNA-tagged liposomes allowing their use in capillary-migration, sand-wich-hybrization assays. RULE, G. S., MONTAGNA, R. A., and DURST, R. A., Ana/. Biochem., 1997, 244 (2), 260–269.
  • Characterization of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived sterylglucoside mixture by differential scanning calorimetry, Fourier transform infra-red spectroscopy, and enzymatic assay. SHivozu, K., MAITANI, Y., TAKAYAMA, K., and NAGAI, T., J. Pharm. Sci., 1996, 85 (7), 741–744.
  • Characterization of microencapsulated liposome systems for the controlled delivery of liposome-associated macromolecules. MACHLUF, M., REGEV, 0., PELED, Y., KOST, J., COHEN, S., J. Controlled Release, 1997, 43 (1), 35–45.
  • Characterization and morphological analysis of a cholecystokinin derivative peptide-loaded poly(lactide-co-glycolide) microspheres prepared by a water-in-oil-in-water emulsion solvent evaporation method. BLANCO, P. M. J., FATTAL, E., GuLiK, A., DEDIEU, J. C., ROQUES, B. P., and COUVREUR, P., J. Controlled Release, 1997, 43 (1), 81–87.
  • Characterization of biotinylated liposomes sensitive to temperature and pH: new tools for anti-cancer drug delivery. FERRARETTO, A., SONNINO, S., SORIA, M. R., and MASSERINI, M., Chem. Phys. Lipids, 1996, 82 (2), 133–139.
  • Characterization of enzyme immobilization in liposomes prepared from proliposomes. DUFOUR, P., VUILLEMARD, J. C., LALOY, E., and SIMARD, R. E., J. Microencapsul., 1996, 13 (2), 185–194.
  • Characterization of fusogenic liposomes as a gene transfer vector. NAKAGAWA, T., MIZUGUCHI, H., ImAzu, S., NAKANISHI, M., NAKAGAWA, S., HAYAKAWA, T., and MAYUMI, T., Drug Delivery Syst., 1996, 11(6), 411–417.
  • Chitosan microspheres of diclofenac sodium: I. application of factorial design and evaluation of release kinetics. ACCIKGOZ, M., ICAs, H. S., ORMAN, M., and HINCAL, A. A., J. Microencapsul., 1996, 13 (2), 141–159.
  • Chitosanicalcium alginate microcapsules for intestinal delivery of nitrofurantoin. HARI, P. R., CHANDY, T., and SHARMA, C. P., J. Microencapsul., 1996, 13 (3), 319–329.
  • Circular dichroic properties of phosphatidylcholine liposomes. WALDE, P., and BLOECHLIGER, E., Langmuir, 1997, 13 (6), 1668–1671.
  • Colored microsphere technique as a new method for quantitative-multiple estimation of regional hepatic and portal blood flow. BAUER, R., WALTER, B., WURKER, E., KLUGE, H., and ZWIENER, U., Exp. Toxicol. Pathol., 1996, 48 (5), 415–420.
  • Combinatorial effects of monoclonal anti-p120 antibody (MAbp120), liposomes and hyperthermia on MCF-7 and LOX tumor cell lines. PERLAKY, L., BUSCH, R. K., and BUSCFI, H., Oncol. Res., 1996, 8 (9), 363–369.
  • Combined modality radioprotection: enhancement of survival and hematopoietic recovery in gamma-irradiated mice by the joint use of liposomal muramyl tripeptide phospha-tidylethanolamine (MTP-PE) and indomethacin. FEDOROCKO, P., and MACKOVA, N. 0., Int. y. Immunopharmacol., 1996, 18 (5), 329–337.
  • Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine. HARVIE, P., DESORMEAUX, A., BERGERON, M. C., TREMBLAY, M., BEAUCHAMP, D., POULIN, L., and BERGERON, M. G., Antimicrob. Agents. Chemother., 1996, 40 (I), 225–229.
  • Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods. DIPALI, S. R., KULKARNI, S. B., and BETAGERI, G. V., J. Pharm. Pharmacol., 1996, 48 (11). 1112–1115.
  • Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclo-dextrin/drug complexes after intravenous injection into rats: implications in drug delivery. MCCORMACK, B., and GREGORIADIS, G., Biochim. Biophys. Acta, 1996, 1291 (3), 237–244.
  • Comparison of the bactericidal action of amikacin, netilmicin and tobramycin in free and liposomal formulation against Pseudomonas aeruginosa. OMRI, A., and RAVAOARINORO, M., Chemotherapy, 1996, 42 (3), 170–176.
  • Competitive immunosorbent assays using ligand-enzyme conjugates bifunctional liposomes: theory and experiment. JONES, M. A., KILPATRICK, P. K., and CARBONELL, R. G., Biotechnol. Prog., 1996, 12 (4), 519–526.
  • Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies. SZEBENI, J., WASSEF, N. M., RUDOLPH, A. S., ALVING, C. R., Biochim. Biophys. Acta, 1996, 1285 (2), 127–130.
  • Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglo-bin: mechanism of activation and inhibition by soluble complement receptor type 1. SZEBENI, J., WASSEF, N. M., HARTMAN, K. R., RUDOLPH, A. S., ALVING, C. R., Transfusion, 1997, 37 (2), 150–159.
  • Compressive deformation of a single microcapsule. Liu, K. K., WILLIAMS, D. R., and BRISCOE, B. J., Phys. Rev. E: Stat. Phys., Plasmas, Fluids, Relat. Interdiscip. Top, 1996, 54(6), 6673–6680.
  • Conformational changes in plant Ins(1,4,5)P3 receptor on interaction with different myo-inositol trisphosphates and its effect on Ca2 + release from microsomal fraction and liposomes. DASGUPTA, S., DASGUPTA, D., CHATTERJEE, A., BISWAS, S., BISWAS, B. B., Biochem. y., 1997, 321 (2), 355–360.
  • Congo Red- and Zn(II)-derivatized monosize poly(MMA-HEMA) microspheres as specific sorbent in metal chelate affinity of albumin. DENIZLI, A., KOKTURK, G., SALIH, B., KOZLUCA, A., and PISKIN, E., J. Appl. Polym. Sci., 1997, 63 (1), 27–34.
  • Control of photocoagulation intensity by thermo-induced release of a fluorescent marker encapsulated in liposomes: study of an in vivo vascular model. DESMETTRE, T., MORDON, S., SOULIE, S., DEVOISSELLE, J. M., and MITCHELL, V., y. Fr. Ophtalmol., 1996, 19(11), 667–678.
  • Controlled relase of ionic compounds from poly(L-lactide) microspheres produced by precipitation with a compressed antisolvent. FALK, R., RANDOLPFI, T. W., MYER, J. KELLY, R. M., and MANNIG, M. C., J. Controlled Release, 1997, 44 (I), 77–85.
  • Controlled release of interleukin-2 for tumor immunotherapy using alginate/chitosan porous microspheres. Liu, L. S., Liu, S. Q., No, S. Y., FROIX, M., OHNO, T., and HELLER, J., J. Controlled Release, 1997, 43 (1), 65–74.
  • Conversion of light energy to proton potential in liposomes by artificial photosynthetic reaction centers. STEINBERG, Y. G., LIDDELL, P. A., HUNG, S. C., MOORE, A. L., GUST, D., and Moore, T. A., Nature (London), 1997, 385 (6613), 239–241.
  • Corticosteroid dermal delivery with skin-lipid liposomes. FRESTA, M., and PuGusi, G., J. Controlled Release, 1997, 44 (2, 3), 141–151.
  • Cryoprotective effects of cycloinulohexaose on freezing and freeze-drying of liposomes. OSAKI, M., HAYASHI, M., Chem. Pharm. Bull., 1966, 44(11), 2116–2120.
  • Degradation of DL-PLA-methadone microspheres during in vitro release. DELGADO, A., EVORA, C., and LLABRES, M., Int. J. Pharm., 1996, 140 (2), 219–227.
  • Delivery of DNA-cationic liposome complexes by small-particle aerosol. SCHWARZ, L. A., JOHNSON, J. L., BLACK, M., CHENG, S. H., HOGAN, M. E., and WALDREP, J. C., Hum. Gene Ther., 1996, 7 (6), 731–741.
  • Determination of regional pulmonary blood flow with systematically injected nonentrapped microspheres. KLEEN, M., ZWISSLER, B., SCHOSSER, R., and MESSMER, K., J. Appl. Physiol., 1996, 81(2), 695–706.
  • Determination of the physical state of drug in microcapsule and microsphere formulations. DASH, A. K., J. Microencapsulation, 1997, 14 (1), 101–112.
  • Determination of the size distribution of lecithin liposomes: A comparative study using freeze fracture, cryoelectron microscopy and dynamic light scattering. EGELHAAF, S. U., WEHRLI, E., MULLER, M., ADRIAN, M., and SCHURTENBERGER, P., J. microsc. (Oxford), 1996, 184 (3), 214–228.
  • Development of a novel method of microencapsulation for a model protein, beta- glucuronidase. SINGH, 0. N., and BURGESS, D. L., Pharm. Sci., 1996, 2 (5), 223-228. Development of slow-release insect repellent microcapsules. UTAKA, K., Konbatekku, 1996, 24 (11), 18–25.
  • Dielectric analysis of phosphorylcholine head group mobility in egg lecithin liposomes. SMITH, G., SHEKUNOV, B., SHEN, J., DUFFY, A. P., ANWAR, J., WAKERLY, M. G., and CHAKRABARTI, R., Pharm. Res., 1996, 13 (8), 1181–1185.
  • Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats. MURAMATSU, K., MAITANI, Y., and NAGAI, T., Biol. Pharm. Bull., 1996, 19 (8), 1055–1058.
  • Direct extraction of A and B blood group antigens from human red cells by liposomes. SUZUKI, K., OKUMURA, Y., SATO, T., YASUDA, T., OKI, M., and SUNAMOTO, J., Transfusion (Bethesda, Md), 1996, (11/12), 966–968.
  • Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. UNEZAKI, S., MARUYAMA, K., HOSODA, J. I., NAGAE, I., KOYANAGI, Y., NAKATA, M., ISHIDA, 0., IWATSURU, M., and TSUCHIYA, S., Int. J. Pharm., 1996, 144 (1), 11–17.
  • Distribution of pulmonary and bronchial blood supply to airways measured by fluorescent microspheres. BERNARD, S. L., GLENNY, R. W., POLISSAR, N. L., LUCHTEL, D. L., and LAKSHMINARAYAN, S., J. Appl. Physiol., 1996, 80 (2), 430–436.
  • Drug release behavior of chitosan/gelatin network polymer microsphere. YIN, Y., XU, M., CHEN, X., and YAO, K., Chin. Sci. Bull., 1996, 41(15), 1266–1270.
  • Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes. BANERJEE, G., NANDI, G., MAHATO, S. B., PAKRASHI, A., and BASU, M. K., J. Antimicrob. Chemother., 1996, 38 (1), 145–150.
  • DSC of DMPC liposomes containing low concentrations of cholesteryl esters or cholesterol. MALCOLMSON, R. J., HIGINBOTHAM, J., BESWICK, P. H., PRIVAT, P. 0., and SAUNIER, L., J. Membr. Sci., 1997, 123 (2), 243–253.
  • Dynamic fluorescence changes during photodynamic therapy in vivo, and in vitro of hydro-philic MOM phthalocyanine tetrasulfonate and lipophilic Zn(II) phthalocyanine ad-ministered in liposomes. RUECK, A., BECK, G., BACHOR, R., AKGUEN, N., GSCHWEND, M. H., and STEINER, R., J. Photochem. Photobiol., B, 1996, 36 (2), 127–133.
  • Effect of macrophage elimination using liposome-encapsulated dichloromethylene diphos-phonate on tissue distribution of liposomes. Hu, Q., VAN ROOLIEN, N., and Liu, D., J. Liposome Res., 1996, 6 (4), 681–698.
  • Effect of matrix lipid chain length on liposomes containing cholesterol and ganglioside GM: implications in drug delivery. BEDU, A. F. K., and HUANG, L., J. Pharm. Sci., 1996, 85 (7), 714–719.
  • Effect of aluminum ion on Fe2+ -induced lipid peroxidation in phospholipid liposomes under acidic conditions. OHYASHIKI, T., KARIN°, T., SUZUKI, S., and MATSUI, K., y. Biochem. (Tokyo), 1996, 120 (5), 895–900.
  • Effect of chitosan-alginate microcapsules on controlled release of drug. FENGQI, L., ZONGSHUN, C., and YAN, Z., Zhongguo Yiyao Gongye Zazhi, 1996, 27 (6), 247–249.
  • Effect of formulation and processing factors on the characteristics of biodegradable micro-capsules of zidovudine. MANDAL, T. K., SHEKLETON, M., ONYEBUEKE, E., WASHINGTON, L., and PENSON, T., J. Microencapsul., 1996, 13 (5), 545–557.
  • Effect of liposome encapsulated hemoglobin "neo red cells" as a resuscitation fluid for severe hemorrhagic shock. USUBA, A., MOTOKI, R., Fuxul, H., OGATA, Y., GOTO, H., KIMURA, T., "rink° Ketsueki, 1996, 4 (3), 69–75.
  • Effect of the method of 99mTc labeling of liposomes on their biological behavior. SABRA, D. C., PIRMETTIS, I., ARCHIMANDRITI, M., PAPADOPOULOS, M., CHIOTELLIS, E., Chem. Chron., Genike Ekdose, 1996, 58 (12), 661–664.
  • Effect of vehicle on topical liposomal drug delivery: petrolatum bases. FOLDVARI, M., 5. Microencapsul., 1996, 13 (5), 589–600.
  • Effect of xanthophyll pigments on fluorescence of chlorophyll a in LHC II embedded to liposomes. GRUSZECKI, W., I., MATULA, M., MYSLIWA, K. B., KERNEN, P., KRUPA, Z., and STRZALKA, K., J. Photochem. Photobiol., B, 1997, 37 (1–2), 84–90.
  • Effect of zeta potential of cationic liposomes containing cationic cholesterol derivatives on gene transfection. TAKEUCHI, K., ISHIHARA, M., KAWAURA, C., NOJI, M., FURUNO, T., and NAKANISHI, M., FEBS-Lett., 1966, Nov. 18, 397 (2-3), 207–209.
  • Effect of microcapsule size and polyisobutylene concentration on the release of theophylline from ethylcellulose microcapsules. SA, B., BANDYOPADHYAY, A. K., and GurrA, B. K., J. Microencapsul., 1996, 13 (2), 207–218.
  • Effect of surfactant agents on the release of 125I-bovine calcitonin from PLGA microspheres: in vitro-in vivo study. DIAZ, R. V., SORIANO, I., DELGADO, A., LLABRES, M., and EVORA, C., J. Controlled Release, 1997, 43 (1), 59–64.
  • Effect of composition and method of preparation of liposomes on their stability and interac-tion with murine monocytes infected with Brucella abortus. VITAS, A. I., DIAZ, R., and GAMAZO, C., Antimicrob. Agents Chemother., 1996, 40 (1), 146–151.
  • Effect of membrane modification by PEG on prolongation of circulation time of liposomes in blood in vivo. Hou, X., ZHANG, J., and Lu, X., Yaoxue Xuebao, 1996, 31(6), 451–454.
  • Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. ZEISIG, R., SHIMADA, K., HIROTA, S., and ARNDT, D., Biochim. Biophys. Acta, 1996, 1285 (2), 237–245.
  • Effects of gamma irradiation on the stability of liposomes/phospholipids. 1. Chemical stability. STENSRUD, G., SMISTAD, G., and KARLSEN, J., Drug Stab., 1996, 1(3), 152–160.
  • Effects of administered route on tissue distribution and antitumor activity of polyethylene glycol-coated liposomes containg adriamycin. SADZUKA, Y NAKAI, S., MIYAGISHIMA, A., NOZAWA, Y., and HIROTA, S., Cancer Lett (Shannon, Irel), 1996, 111 (1, 2), 77–86.
  • Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis. KRETSCHMAR, M., NICHTERLEIN, T., HANNAK, D., and HOF, H., Arzneimittelforschung, 1996, 46 (7), 711–715.
  • Effects of lipid compositions on thermo-sensitivity of stratum corneum lipid liposomes. SUMIDA, Y NISHIO, H., lwAmo-ro, Y., and MIYAJIMA, K., Maku, 1996, 21(5), 326–333.
  • Effects of membrane charges and hydroperoxides on Fe(II)-supported lipid peroxidation in liposomes. TAMPO, Y., and YONAFIA, M., Lipids, 1996, 31(10), 1029–1038.
  • Effects of morphine and liposomal morphine in a model of intestinal inflammation in mice. PoL., 0., PLANAS, E., Puic, M. M., Pharmacology, 1996, 53 (3), 180–189.
  • Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implica-tions in liposomal drug delivery. BEDU, A. F. K., TANG, P., Xu, Y., HUANG, L., Pharm. Res., 1996, 13 (5), 710–717.
  • Effects of ethanol on permeability of phosphatidylcholine/cholesterol mixed liposomal membranes. KOMATSU, H., and OKADA, S., Chem. Phys. Lipids, 1997, 85 (1), 67–74.
  • Effects of liposome size on penetration of dl-tocopherol acetate into skin. NATSUKI, R., MORITA, Y OSAWA, S., and TAKEDA, Y., Biol. Pharm. Bull., 1996, 19 (5), 758–761.
  • Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. NORTHFELT, D. W., DEZUBE, B. J., THOMMES, J. A., LEVINE, R., VON ROENN, J. H., DOSIK, G. M., Rios, A., KNOWN, S. E., DUMOND, C., and MAMELOK, R. D., J. Clin. Oncol., 1997, 15 (2), 653–659.
  • Efficient oligonucleotide delivery using the HVJ-liposome method in the central nervous system. YAMADA, K., MORIGUCHI, A., MORISHITA, R., AOKI, M., NAKAMURA, Y MIKAMI, H., OSHIMA, T., NINOMIYA, M., KANEDA, Y., et al., Am. J. Physiol., 1996, 271 (5, Pt. 2), R1212–R1220.
  • Elaboration and specific properties of fluorinated liposomes and related supramolecular systems. KRAFFT, M. P., and RIESS, J. G., Cell Mol. Biol. Lett., 1996, 1(4), 459–468.
  • Empirical liposomal amphotericin-B therapy in a neutropenic patient: breakthrough of disseminated Blastoschizomyces capitatus infection. PLUM, G., SCHEID, C., FRANZEN, C., ScHurr, G. H., SEIFERT, H., and WICKRAMANAYAKE, P. D., Zentralbl. Bakteriol., 1996, 284 (2-3), 361–366.
  • Encapsulation of native crotoxin in liposomes; a safe approach for the production of antivenom and vaccination against Crotalus durissus terrificus venom. FREITAS, T. V., and FREZARD, F., Toxicon, 1997, 35 (1), 91–100.
  • Encapsulation of vancomycin and gentamicin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis. SANDERSON, N. M., and JoNcs, M. N., J. Drug Targeting, 1996, 4 (3), 181–189.
  • Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation. GOMEZ, F. R., HSIA, R., TAMEZ, G. R., and MEHTA, R. T., Antimicrob. Agents Chemother., 1966, 40(11), 2545–2549.
  • Enhanced delivery of synthetic oligonucleotides to human leukemic cells by liposomes and immunoliposomes. MA, D. D. F., and WEI, A. Q., Leuk. Res., 1996, 20 (11/12), 925-930. Enhancement of the antibacterial activity of ampicillin by liposome encapsulation. SAMMOUR, 0. A., and HASSAN, H. M., Drug Delivery, 1996, 3 (4), 273–278.
  • Enhancement of oxygen transfer rate using microencapsulated silicone oils as oxygen carriers. LEUNG, R., PONCELET, D., and NEUFELD, R. J., J. Chem. Technol. Biotechnol., 1997, 68 (1), 37–46.
  • Enzyme therapy of xeroderma pigmentosum: safety and efficacy testing of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme. YAROSH, D., KLEIN, J., KIBITEL, J., ALAS, L., 0-CoNNoll, A., CUMMINGS, B., GROB, D., GERSTEIN, D., GILCHREST, B. A., ICHIHASHI, M., OGOSHI, M., UEDA, M., FERNANDEZ, V., CHADWICK, C., POTTEN, C. S., PROBY, C. M., YOUNG, A. R., HAWK, J. L., Photodermatol. Photoimmunol. Photomed., 1996, 12 (3), 122–130.
  • Enzyme-containing liposomes can endogenously produce membrane-constituting lipids. WICK, R., and Luis', P. L., Chem. Biol., 1966, 3 (4), 277–285.
  • Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramy-cM in an animal model of chronic pulmonary infection. BEAULAC, C., CLEMENT, M. S., HAWARI, J., and LAGACE, J., Antimicrob. Agents. Chemother., 1996, 40 (3), 665–669.
  • Evaluation of microcapsule permeability via inverse size exclusion chromatography. BRISSOVA, M., PETRO, M., LACIK, I., POWERS, A. C., and WANG, T., Anal. Biochem., 1996, 242 (1), 104–111.
  • Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method. PAVANETTO, F., PERUGINI, P., CONTI, B., MODENA, T., and GENTA, I., J. Microencapsul., 1996, 13 (6), 679–688.
  • Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis. WASAN, K. M., and CONKLIN, J. S., Antimicrob. Agents Chemother., 1996, 40 (8), 1806–1810.
  • Examination of the toxicity of the liposomal form of amsacrine and retinoic acid. TARASIUK, A., Acta Pol. Pharm., 1992, 49 (1-2), 17–20.
  • Expression of Neisseria meningitidis class 1 porin as a fusion protein in Escherichia coli: The influence of liposomes and adjuvants on the production of a bactericidal immune re-sponse. WARD, S. J., SCOPES, D., CHRISTODOULIDES, M., CLARKE, I. N., and HECKELS, J. E., Microb. Pathog., 1996, 21(6), 499–512.
  • Exptl. study on intraperitoneal transplantation of microencapsulated fetal-pituitary-hypotha-lamic-nigral-cells in hypophysectomized rabbits. WANG, Y., ZHANG, N., PENG, C., and Lu, S., Jiangsu Yiyao, 1996, 22 (11), 751–753.
  • Extracorporeal removal of proinflammatory cytokines by specific absorption onto microspheres. WEBER, C., and FALKENHAGEN, D., ASA/04, 1996, 42 (5), M908–911.
  • Fabrication of microcapsules using poly(ethylene adipate) and a blend of poly(ethylene adipate) with poly(hydroxybutyrate-hydroxyvalerate): Incorporation and release of bovine serum albumin. ATKINS, T. W., Biomaterialss, 1997, 18 (2), 173–180.
  • Factors influencing the encapsulation of thioguanine in DRV liposomes. CASALS, E., GALLARDO, M., and ESTELRICH, J., Int. J. Pharm., 1996, 143 (2), 171–177.
  • Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Liu, Y., MOUNKES, L. C., LIGGITT, H. D., BROWN, C. S., SOLON, I., HEATH, T. D., and DEBS, R. J., Nat. Biotechnol., 1997, 15 (2), 167–173.
  • Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values. KRUGER, W., SOBOTTKA, I., STOCKSCHLADER, M., MROSS, K., HOFFKNECHT, M., RUSSMANN, B., HORSTMANN, M., BETKER, R., and ZANDER, A., Scand. J. Infect. Dis., 1996, 28 (3), 313–316.
  • Fibrin binding of plasminogen coated liposomes in vitro. HEEREMANS, J. L., Los, P., PREVOST, R., CROMMELIN, D. J., and KLUFT, C., Thromb. Haemost., 1996, 75 (1), 134–139.
  • Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres. ST PIERRE, Y., DESROSIERS, M., TREMBLAY, P., ESTEVE, P. 0., and OPDENAKKER, G., Cytometry, 1996, 25 (4), 374–380.
  • Fluorescent probe studies of ribonuclease and lysozyme interactions with liposomes. GORBENKO, G. P., Biofizika, 1996, 41(5), 1038–1043.
  • Forensic analysis of 10 barbiturates in human biological samples using a new reversed-phase chromatographic column packed with 2-micrometer porous microspherical silica-gel. TANAKA, E., TERADA, M., TANNO, K., MISAWA, S., and WAKASUGI, C., Forensic Sci. Int., 1997, 85 (1), 73–82.
  • Formation of biocompatible polymer microspheres for controlled drug delivery by a super-critical antisolvent technique. BERTUCCO, A., PALLADI, P., and BENEDETTI, L., Process Technol. Proc., 1996, 12, 217–222.
  • Formulation of bovine serum albumin loaded PLGA microspheres. Influence of the process variables On the loading and in vitro release. MARCHAIS, H., BOURY, F., DAMGE, C., PROUST, J. E., and BENOIT, J. P., STP Pharma. Prat., 1996, 6 (6), 417–423.
  • Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres. Owusu, A., and ROGERS, J. A., J. Microencapsul., 1996, 13 (2), 195–205.
  • Formulation of poly(DL-lactide-co-glycolide) microspheres and their ingestion by bovine leukocytes. O'BRIEN, C. N., and GUIDRY, A. J., J. Dairy Sci., 1996, 79 (11), 1954–1959.
  • Formulation of BCNU-loaded microspheres: influence of drug stability and solubility on the design of the microencapsulation procedure. TORRES, A. I., BOISDRON, C. M., and BENOIT, J. P., J. Microencapsul., 1996, 13 (1), 41–51.
  • Formulation and characterization of azidothymidine-loaded liposomes. RAVIVARAPU, H., and WHITE, C. A., Drug Delivery, 1996, 3 (4), 223–229.
  • Free radicals from 1-palmitoy1-2-arachidonoylphosphatidylcholine liposomes in Fe2 + / ascorbic acid solution. YOSHIDA, T., OTAKE, H., ARAMAKI, Y., HARA, T., TSUCHIYA, S., HAMADA, A., and UTSUMI, H., Biol. Pharm. Bull., 1996, 19 (6), 779–782.
  • Functional reconstitution of photosystem I reaction center from cyanobacterium Synecho-cystis sp PCC6803 into liposomes using a new reconstitution procedure. CLADERA, J., RIGAUD, J. L., Borrirst, H., and DUNACH, m., J. Bioenerg. Biomembr., 1996, 28(6), 503–515.
  • Fusion between Jurkat cell and PEO-lipid modified liposome. HIGASHI, N., YAMAUCHI, M., OKUMURA, Y., NAKANISHI, M., and SUNAMOTO, J., Biochim. Biophys. Acta, 1996, 1285 (2), 183–191.
  • Gelatin microsphere cocktails of different sizes for the controlled release of anticancer drugs. NARAYANI, R., and PANDURANGA, R. K., Int. J. Pharm., 1996, 143 (2), 255-258. Generation of streaming potential by liposomes in cylindrical capillary. A physical model. ZAWADA, Z. H., Gen. Physiol. Biophys., 1996, 15 (2), 165–173.
  • Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. CASTILLO, J., CURLEY, J., HOTZ, J., UEZONO, M., TIGNER, J., CHASIN, M., WILDER, R., LANGER, R., and BERDE, C., Anesthesiology, 1996, 85 (5), 1157–1166.
  • High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency. GREGORIADIS, G., SAFFIE, R., and HART, S. L., y. Drug Target., 1996,3 (6), 469–475.
  • Human epidermal melanocyte and keratinocyte melanocortin receptors: visualization by melanotropic peptide conjugated microspheres (latex beads). JIANG, J., SHARMA, S. D., HRUBY, V., BENTLEY, D. L., FINK, J. L., and HADLEY, M. E., Pigm. Cell Res., 9 (5), 240–247.
  • Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated mel-phalan in murine tumors. CHELVI, T. P., JAIN, S. K., and RALHAN, R., Oncol. Res., 1995, 7 (7–8), 393–398.
  • Identification of pro-oxidant or antioxidant characteristics of proteins and enzymes in membranes; use of liposome-entrapped proteins and other thiol-containing compounds. STRAGHAN, E., SHARMA, G., GOLDFARB, P., and WISEMAN, A., Biochem. Soc. Trans., 1966, 24 (3), 375S.
  • Imaging of liposomes by scanning tunnelling microscopy. ZAREIE, M. H., BORUCU, A., OZDEN, M. Y., HASIRCI, V., and PICSKIN, E., Arti f. Cells Blood Substit. Immobil. Biotechnol., 1966, 24(5), 525–531.
  • Immobilized chymotrypsin on reversibly precipitable polymerized liposome. SUN, Y., JIN, X. H., DONG, X. Y., Yu, K., and ZHOU, X. Z., Appl. Biochem. Biotechnol., 1996, 56 (3), 331–339.
  • Immobilized liposome chromatography of drugs for model analysis of drug—membrane interactions. LUNDAHL, P., and Betci, F., Adv. Drug Delivery Rev., 1997, 23 (1-3), 221–227.
  • Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)-lysine-alginate (AP) membrane following allogeneic transplantation. OKADA, N., MIYAMOTO, H., YOSHIOKA, T., SAKAMOTO, K., KATSUME, A., SAITO, H., NAKAGAWA, S., OHSUGI, Y., and MAYUMI, T. Biochem. Biophys. Res. Commun., 1997, 230 (3), 524–527.
  • Importance of liposome complexing volume in transfection optimization. STAGGS, D. R., BURTON, D. W., and DEFros, L. J., Biotechniques, 1996, 21(5), 792, 784, 796, 798.
  • In vitro biodegradation of polyhydroxybutyrate-hydroxyvalerate microcapsules exposed to Hank's buffer, newborn calf serum, pancreatin and synthetic gastric juice. ATKINS, T. W., and PEACOCK, S. J., J. Microencapsulation, 1997, 14 (1), 35–49.
  • In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin prepara-tions at different pH values. GAN, K. H., GEUS, W. P., BAKKER, W., LAMERS, C. B., HEIJERMAN, H. G., Aliment. Pharmacol. Ther., 1996, 10 (5), 771–775.
  • In vitro analysis of the release of incorporated agents from sodium caseinate microspheres. HEELAN, B. A., and CORRIGAN, 0. I., J. Microencapsulation, 1997, 14(1), 63–78.
  • In vitro evaluation of the hydrolytic degradation of dispersed and aggregated poly(DL-lactide-co-glycolide) microspheres. SANsoRAp, P., and MOEES, A. J., J. Controlled Release, 1997, 43 (1), 47–58.
  • In vitro penetration into bovine oocytes and zona-free hamster oocytes by bull spermatozoa treated with liposomes. TRUELSON, S. L., GRAHAM, J. K., MORTIMER, R. G., and FIELD, T. G., J. Dairy Sci., 1996, 79 (6), 991–999.
  • In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement. DEMOS, S. M., ONYUKSEL, H., GILBERT, J., ROTH, S. I., KANE, B., JUNGBLUT, P., PINTO, J. V., MCPHERSON, D. D., and KLEGERMAN, M. E., J. Pharm. Sci., 1997, 86 (2), 167–171.
  • In vitro comparison of cytokine release from antithymocyte serum and OKT3. Inhibition with soluble and microencapsulated neutralizing antibodies. OETTINGER, C. W., D'SouzA, M., and MILTON, G. V., Transplantation, 1996, 62 (11), 1690–1693.
  • In vivo behavior of poly(D, L)-lactide microspheres designed for chemoembolization. FLANDROY, P., GRANDLS, C., DAENEN, B., SNAPS, F., DONDELINGER, R. F., JEROME, R., BASSLEER, R., HEINEN, E., J. Controlled Release, 1997, 44 (2, 3), 153–170.
  • In vivo colored microspheres in the isolated rat heart for use in NMR. HILLER, K. H., ADAM, P., VOLL, S., RODER, F., KOWALLIK, P., BAUER, W. R., HAASE, A., and ERTL, G., J. Mol. Cell Cardiol., 1966, 28 (3), 571–577.
  • In vivo distribution of radioactivity in mice after injection of biodegradable polymer micro-spheres containing 14C-labeled tetanus toxoid. GUPTA, R. K., CHANG, A. C., GRIFFIN, P., RIVERA, R., and SIBER, G. R., Vaccine, 1996, 14 (15), 1412–1416.
  • In vivo gene transfer into the retina mediated by a novel liposome system. HANGAI, M., KANEDA, Y., TANIHARA, H., and HONDA, Y., Invest. Ophthalmol. Vis. Sci., 1996, 37 (13), 2678–2685.
  • In vitro transfection of rat liver with hepatitis C virus cDNA using cationic liposome-mediated gene delivery. HAYASHI, N., TAKEHARA, T., and KAMADA, T., Princess Takamatsu Symp., 1995, 25, 143–149 22 Refs.
  • In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method. SAWAMURA, D., MEND, X., INA, S., ISHIKAWA, H., TAMAI, K., NOMURA, K., HANADA, K., HASHIMOTO, I., and KANEDA, Y., J. Invest. Dermatol., 1997, 108 (2), 195–199.
  • In vitro antibacterial activity of liposomal polymyxin B incorporated into collagen sponge. TRAFNY, E. A., ANTOS, B. M., and GRZYBOWSKI, J., Cell Mol. Biol. Lett., 1996, 1(4), 357–361.
  • In vitro studies on a new method for islet microencapsulation using a thermoreversible gelatin polymer, N-isopropylacrylamide-based copolmer. SHIMIZU, S., YAMAZAKI, M., KUBOTA, S., OZASA, T., MORIYA, H., KOBAYASHI, K., MIKAMI, M., MORI, Y., and YAMAGUCHI, S., Artif. Organs, 1996, 20(11), 1232–1237.
  • In vitro-in vivo myotoxicity of intramuscular liposomal formulations. AL SUWAYEH, S. A., TEBBETT, I. R., WIELBO, D., and BRAZEAU, G. A., Pharm. Res., 1966, 13 (9), 1384–1388.
  • In vivo evaluation of mitomycin C-poly(lactic acid) microcapsules via canine intrahepatic arterial infusion. MEHTA, R. C., SECRIST, R. D., BALIAN, A. A., HOGAN, T. F., MA, J. K. H., Drug Delivery, 1996, 3 (4), 263–271.
  • In-vitro studies of enteric coated diclofenac sodium-carboxymethylcellulose microspheres. ARICA, B., ARICA, M. Y., KAS, H. S., HINCAL, A. A., and HASIRCI, v., J. Microencapsul., 1996, 13 (6), 689–699.
  • In-vitro evaluation of ion-exchange microspheres as carriers for plasmid DNA. DASS, C. R., WALKER, T. L., DECRUZ, E. E., and BURTON, M. A., Pharm. Sci., 1996, 2 (9), 401-405. In-vitro evaluation of sustained release ibuprofen microspheres. GHALY, E. S., and SEPULVEDA, S., P. R. Health Sci. J., 1996, 15 (2), 97–100.
  • In-vivo studies in the treatment of oral ulcers with liposomal dexamethasone sodium phosphate. FARSHI, F. S., OZER, A. Y., ERCAN, M. T., and HINCAL, A. A., J. Microencapsul., 1996, 13 (5), 537–544.
  • In-vivo studies on dexamethasone sodium phosphate liposomes. AL MUHAMMED, J., OZER, A. Y., ERCAN, M. T., and HINCAL, A. A., J. Microencapsul., 1996, 13 (3), 293–306.
  • Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome. OHISHI, K., KABEYA, H., AMANUMA, H., and ONUMA, M., Vaccine, 1996, 14(12), 1143–1148.
  • Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. MEN, Y., GANDER, B., MERKLE, H. P., CORRADIN, G., Vaccine, 1996, 14 (15), 1442–1450.
  • Influence of DNA on the ultrastructural organization of lecithin liposomes in presence of calcium cations. TARAKHOVSKII, Y. S., KHUSAINOVA, R. S., GORELOV, A. V., DAVSON, K. A., and IVANITSKII, G. R., Dokl Akad Nauk, 1996, 350 (3), 411–413.
  • Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. PHILLIPS, N. C., GAGNE, L., IVANOFF, N., and RIVEAU, G., Vaccine, 1996, 14 (9), 898–904.
  • Infrared quantitative study of acetylation of microspheres of polystyrene. Liu, X., BAYER, A. K., and XUE, G., Spectrosc Lett., 1997, 30 (1), 17–23.
  • Inhibition of liposomal lipid peroxidation by isofiavonoid type phyto-oestrogens from soy-beans of different countries of origin. WISEMAN, H., Lim, P., O'REILLy, J., Biochem. Soc. Trans., 1996, 24 (3), 392S.
  • Interaction between nicardipine hydrochloride and polymeric microspheres for a controlled release system. YUKSEL, N., TINCER, T., and BAYKARA, T., Int. j. Pharm., 1996, 140 (2), 145–154.
  • Interaction of polyethyleneglycol-phospholipid conjugates with cholesterol-phosphatidylcho-line mixtures: sterically stabilized liposome formulations. BEDU, A. F. K., TANG, P., Xu, Y., HUANG, L., Pharm. Res., 1996, 13 (5), 718–724.
  • Interaction of photosensitizers with membranes of liposomes and of erythrocytes. KLEBANOV, G. I., STRANADKO, E. F., TESELKIN, Y. 0., BABENKOVA, I. V., and CHICHUK, T. V., Proc. SPIE Int. Soc. Opt. Eng., 1996, 2924, 205–211.
  • Interaction of liposomes with human skin in vitro—the influence of lipid composition and structure. KIRJAVAINEN, M., URTTI, A., JAASKELAINEN, I., SUHONEN T., M., PARONEN, P., VALJAKKA, K. R., MOENKKOENEN, J., Biochim. Biophys. Acta, 1996, 1304 (3), 179–189.
  • Interfacial/free radical polymerization microencapsulation: kinetics of particle formation. MAHABADI, H. K., NG, T. H., and TAN, H. s., y. Microencapsul., 1996, 13 (5), 559-573. Intestinal absorption of PLAGA microspheres in the rat. DAMGE, C., APRAHAMIAN, M., MARCHAIS, H., BENOIT, J. P., and PINGET, M., y. Anat., 1996, 189 (Pt 3), 491–501.
  • Intracellular distribution of oligonucleotides delivered by cationic liposomes: light and electron microscopic study. LAPPALAINEN, K., MIETTINEN, R., KELLOKOSKI, J., JAASKELAINEN, I., and SYRJANEN, S., y. Histochem. Cytochem., 1997, 45 (2), 265–274.
  • Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres. VAN, C., RILL, W. L., MALLI, R., HEWETSON, J., NASEEM, H., TAMMARIELLO, R., and KENDE, M., Vaccine, 1996, 14(11), 1031–1038.
  • Intravenous treatment of Leishmania donovani infected mice with liposomal hexadecylphosphocholine. KAUFMANN, K. P., KUHLENCORD, A., EIBL, H., Cell Mol. Biol. Lett., 1996, 1(4), 429–437.
  • Investigation of in-vitro release characteristics of NSAID-loaded polylactic acid microspheres. Gutztou, B., ARMSTRONG, D. J., ELLiorr, P. N., FORD, J. L., and ROSTRON, C., y. Microencapsul., 1996, 13 (6), 701–708.
  • Iron(III)-carboxymethylchitin microsphere for the pH-sensitive release of 6-mercaptopurine. MI, F. L., CHEN, C. T., TSENG, Y. C., KUAN, C. Y., SHYU, S. S., y. Controlled release, 1997, 44 (1), 19–32.
  • Kinetics of cytokine gene expression in macrophage and endothelial cell lines following liposome encapsulated haemoglobin (LEH) treatment in vitro. ZHU, X. L., GAFNEY, W. C., PACHECO, N. D., and ROLLWAGEN, F. M., Cytokine, 1996, 8 (7), 541–547.
  • Labeling of RNA transcripts of eukaryotic cells in culture with BrUTP using a liposome transfection reagent (DOTAP). HAUKENES, G., SZILVAY, A. M., BROKSTAD, K. A., KANESTROEM, A., and KALLAND, K. H., BioTechniques, 1997, 22 (2), 308–312.
  • Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigra-phy? OYEN, W. J., BOERMAN, 0. C., STORM G., VAN BLOOIS, L., KOENDERS, E. B., CROMMELIN, D. J., VAN DER MEER, J. W., and CORSTENS, F. H., Nucl. Med. Commun., 1996, 17 (9), 742–748.
  • Large scale production of DC-Chol cationic liposomes by microfluiclization. SORGI, F. L., and HUANG, L., Int. y. Pharm., 1996, 144 (2), 131–139.
  • Laser induced fluorescence specroscopy of AlPc4 and liposomal ZnPc in a rat bladder tumor model and correlation with PDT efficiency. EDINAK, N., RUCK, A., STAINER, R., GENZE, F. and LOSCTENOV, V., Proc. SPIE Int. Soc. Opt. Eng., 1996, 2924, 266–267.
  • Lectin-bearing polymerized liposomes as potential oral vaccine carriers. CHEN, H., TORCHILIN, V., and LANCER, R., Pharm. Res., 1996, 13 (9), 1378–1383.
  • Lipid peroxidation in egg phosphatidylcholine liposomes: comparative studies on the induc-tion systems Fe2 + /ascorbate and Fe(3 + )-chelates/xanthine-xanthine oxidase. FUKUZAWA, K., IEMURA, M., and TOKUMURA, A., Biol. Pharm. Bull., 1996, 19 (5), 665–671.
  • Lipo-PGE1, prostaglandin El incorporated in lipid microspheres, protects injury of the liver caused by warm ischemia reperfusion. EGASHIRA, T., Kirvi, Y. I., TAKAYAMA, F., KUDO, Y., and YAMANAKA, Y., Free Radic. Biol. Med., 1996, 21(3), 353–356.
  • Lipophilic 1-betaD-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. SCHWENDENER, R. A., ScHorr, H.,.7. Cancer Res. Clin. Oncol., 1996, 122 (12), 723–726.
  • Liposomal formulations containing sodium mercaptoundecahyd.rododecaborate (BSH) for boron neutron capture therapy. MEHTA, S. C., LAI, J. C., and Lu, D. R., J. Microencapsul., 1996, 13 (3), 269–279.
  • Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonary aspergillosis. LEENDERS, A. C., DE MARIE, S., TEN KATE, M. T., BAKKER-WOUDENBERG, I. A., and VERBRUGH, H. A., J. Antimicrob. Chemother., 1996, 38 (2), 215–225.
  • Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improve-ment of cell sensitization to ganciclovir. ZERROUQI, A., RIXE, 0., GHOUMARI, A. M., YAROVOI, S., V., MOUAWAD, R., KFIAYAT, D., and SOUBRANE, C., Cancer Gene Ther., 1996, 3 (6), 385–392.
  • Liposomal formulations of Cu, Zn-superoxide dismutase: physico-chemical characterization and activity assessment in an inflammation model. CORVO, M. L., MARTINS, M B., FRANCISCO, A. P., MORAIS, J. G., and CRUZ, M. E. M., J. Controlled Release, 1997, 43 (1), 1–8.
  • Liposomal induction of a heat-stable macrophage priming factor to induce nitric oxide in response to LPS. ARAMAKI, U., ARIMA, H., HARA, T., and TSUCHIYA, S., Pharm. Res., 1996, 13 (9), 1389–1392.
  • Liposomal phosphatidylserine inhibits tumor cytototoxicity of liver macrophages induced by muramyl dipeptide and lipopolysaccharide. DAEMEN, T., REGTS, J., and SCHERPHOF, G. L., Biochim. Biophys. Acta., 1996, 1285 (2), 219–228.
  • Liposomal targeting of leukemia HL60 cells induced by transferrin-receptor endocytosis. SARTO, P., GINOBBI, P., D'AGOSTINO, I., ARANCIA, G., LENDARO, E., MOLINARI, A., IPPOLITI, R., and CITRO, G., Biotechnol. Appl. Biochem., 1996, 24 (3), 269–276.
  • Liposomal amikacin for treatment of M. avium infections in clinically relevant experimen-tal settings. EHLERS, S., BUCKE, W., LEITZKE, S., FORTMANN, L., SMITH, D., HANSCH, H., HAHN, H., BANCRO, G., and MuLLER, R., Zentralbl. Bakteriol., 1996, 284 (2-3), 218–231.
  • Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model. PETERSEN, E. A., GRAYSON, J. B., HERSH, E. M., DOER, R. T., CHIANG, S. M., OKA, M., and PROFFITT, R. I., J. Antimicrob. Chemother., 1996, 38 (5), 819–828.
  • Liposomal doxorubicin. LINSKY, K. F., and IGNOFFO, R. J., Cancer Pract., 1996, 4 (5), 288–290. 7 Refs.
  • Liposomal doxorubicin. TARDI, P. G., BOMAN, N. L., and Cum.'s, P. R., J. Drug Target, 1996, 4(3), 129–140. 58 Refs.
  • Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity. RICHARDS, R. L., ALVING, C. R., and WASSEF, N. M., J. Pharm. Sci., 1996, 85 (12), 1286–1289.
  • Liposome electrokinetic chromatography as a novel tool for the separation of hydrophobic compounds. NAKAMURA, H., SUGIYAMA, I., and SANO, A., Anal. Sci., 1996, 12 (6), 973–976.
  • Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. MEHTA, R. T., Antimicrob. Agents Chemother., 1996, 40 (8), 1893–1902.
  • Liposome and phospholipid adsorption on a platinum surface studied in a flow cell designed for simultaneous quartz crystal microbalance and ellipsometry measurements. TJAERNHAGE, T., and Puu, G., Colloids Surf, B, 1996, 8 (1/2), 39–50.
  • Liposome-delivered 131I-labeled Zn(H)-phthalocyanine as a radiodiagnostic agent for tumors. POLO, L., SEGALLA, A., Join, G., BOCCHIOTTI, G., VERNA, G., FRANCESHINI, R., MOSCA, R., and DE FILIPPI, P. G., Cancer Lett. (Shannon, Irel), 1996, 109 (1, 2), 57–61.
  • Liposome-entrapped phenytoin locally suppresses amygdaloid epileptogenic focus created by db-cAMP/EDTA in rats. MORI, N., KUROKOUCHI, A., OSONOE, K., SAITOH, H., ARIGA, K., SUZUKI, K., and IWATA, Y., Brain Res., 1995, 703 (1-2), 184–190.
  • Liposome-like fucopeptides as sialyl Lewis X mimetics. LIN, C. C., KIMURA, T., Wu, S. H., WEITZ, S. G., and WoNG, C. H., Bioorg. Med. Chem. Lett., 1996 6 (22), 2755–2760.
  • Liposome-mediated DNA vaccination. GREGORIADIS, G., SAFFIE, R., DESOUZA, J. B., FEBS Lett., 1997, 402 (2, 3), 107–110.
  • Liposomes and immunoliposomes as drug delivery systems in cancer chemotherapy. DEMETZOS, C., Pharmakeutike, 1996, 9 (2), 71–78.
  • Liposomes in ophthalmology. Review of the literature. DESMETTRE, T., MORDON, S., Souue, S., DEVOISSELLE, J. M., WEISSLINGER, J. M., J. Fr. Ophtalmol., 1996, 19(11), 716-731, 72 Refs. Liposomes in pharmaceutics and cosmetics. 2. Uses and results. KREMPEL, H., LILL, N. PZ Prisma, 1997, 4 (1), 46–54.
  • Liposomes, phosphatidylcholine nanoemulsions. GARIEB, J., HOFF, E., and RADOS, S. B., Parfums, Cosmet, Actual, 1996, 131, 63–66.
  • Liposomes. SHARATA, H. H., and KATZ, K. H., Int. J. Dermatol., 1996, 35 (11), 761-769, 75 Refs. Liposomes. Structure and manufacture. NOTHELLE, R., and HAMANN, H. J., Chem. Ing. Tech., 1996, 68(12), 1537–1545.
  • Location of ubiquinone homologues in liposome membranes studied by fluorescence anisotropy of diphenyl-hexatriene and trimethylammonium-diphenyl-hexatriene. JEMIOLA, R. M., KRUK, J., SKOWRONEK, M., and STRZALICA, K., Chem. Phys. Lipids., 1996, 79 (1), 55–63.
  • Long circulating liposomes of 2',3'-dideoxyinosine: formulation and stability. DIPALI, S. R., SINGH, M., and BETAGERI, G. V., Drug Delivery, 1996, 3 (4), 279–287.
  • Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differential airway epithelial cells. MATSUI, H., JOHNSON, L. G., RANDELL, S. H., and BOUCHER, R. c., y. Biol. Chem., 1997, 272 (2), 1117–1126.
  • Lung CuZn-superoxide dismutase and catalase gene expression in premature rabbits treated intratracheally with antioxidant-surfactant liposome. WALTHER, F. J., MEHTA, E. I., and PADBURY, J. F., Biochem. Mol. Med., 1996, 59 (2), 169–173.
  • Lymphotropic delivery of cyclosporin A by intramuscular injection of biodegradable micro-spheres in mice. YOSHIKAWA, H., and SEEBACH, S., Biol. Pharm. Bull., 1996, 19 (11), 1527–1529.
  • Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size. Zou, Y., PRIEBE, W., and PEREZ, S. R., Cancer Chemother. Pharmacol., 1996, 39 (1-2), 103–108.
  • Macroaggregated albumin potentiates the hypoglycemic effect of microencapsulated islets in the fed state of streptozotocin-induced diabetic mice. Hsu, B. R. S., Fu, S. H., HUANG, Y. Y., Hsu, A. W., CHUANG, K. L., and HUANG, H. s., y. Microencapsulation, 1997, 14(1), 27–34.
  • Medical application of microencapsulating hybridoma cells in agarose microbeads 'cyto-medicine': therapeutic effect on IgG1 plasmacytosis and mesangio-proliferative glo-merulonephritis in the interleukin 6 transgenic mouse. OKADA, N., MIYAMOTO, H., KANEDA, Y., YAMAMOTO, Y., KATSUME, A., SAITO, H., YOROZU, K., UEDA, 0., TSUTSUMI, Y., et al. J. Controlled Release, 1997, 44 (2, 3), 195–200.
  • Membrane fusion with cationic liposomes: effects of target membrane lipid composition. BAILEY, A. L., Cutus, P. R., Biochemistry, 1997, 36 (7), 1628–1634.
  • Membrane permeability and stability in buffer and in human serum of fluorinated di-0-alkylglycerophosphocholine-based liposomes. RAVILY, V., SANTAELLA, C., and VIERLING, P., Biochim. Biophys. Acta, 1996, 1285 (1), 79-90. Method for evaluating intestinal transit behavior of microsphere dosage forms. SucimoTo, K., YATA, T., KUROSAKI, Y., NAKAYAMA, T., KIMURA, T., Yakuzaigaku, 1996, 56 (4), 246–250.
  • Methods of hardening gelatin microcapsules. BROUWER, Z. N., BOH, B., Farm. Vestn. (Ljubljana), 1996, 47 (4), 433–447.
  • Microcapsule formation in self-assembly of thermal heterocomplex molecules from amino acids. SAKURAZAWA, S., 'MM, E., HONDA, H., and MATSUNO, K., Colloid Polym. Sc., 1996, 274 (9), 899–903.
  • Microencapsulated Eudragit RS30 D-coated controlled-release pellets: the influence of dis-solution variables and topographical evaluation. GOVENDER, T., DANGOR, C. M., and CHETTY, D. J., J. Microencapsulation, 1997, 14 (I), 1–13.
  • Microencapsulated vaccines to provide prolonged immunity with a single administration. WHALEN, R. L., DEMPSE, D. J., THOMPSON, L. M., BUCKNELL, K., KUNITOMO, R., OKAZAKI, Y., and HARASAKI, H., ASA/O-J., 1996, 42 (5), M649–654.
  • Microencapsulation of allopurinol by solvent evaporation and controlled release investiga-tion of drugs. ARABI, H., HASHEMI, S. A., and FOOLADI, M., J. Microencapsul., 1996, 13 (5), 527–535.
  • Microencapsulation of ketoprofen using w/o/w complex emulsion technique. EL GIBALY, I., SAFWAT, S. M., and AHMED, M. o., J. Microencapsul., 1996, 13 (1), 67–87.
  • Microencapsulation of an iron chelator for sustained release and crystal habit modification. VENKATARAM, S., and KHOHLOKWANE, M., J. Microencapsul., 1996, 13 (5), 519–525.
  • Microencapsulation of drugs by the coacervation technique using ethylcellulose and acry-late-methacrylate copolymer as wall materials. NIMMANNIT, U., and SUWANPATRA, N., J. Microencapsul., 1996, 13 (6), 643–649.
  • Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method. UCHIDA, T., YAGI, A., ODA, Y.,GOTO, S., J. Microencapsul., 1996, 13 (5), 509–518.
  • Microencapsulation of theophylline using ethyl cellulose: /n vitro drug release and kinetic modeling. LAVASANIFAR, A., GHALANDARI, R., ATAEI, Z., ZOLFAGHARI, M. E., and MORTAZAVI, S. A., J. Microencapsulation, 1997, 14 (1), 91–100.
  • Microencapsulation for cell implants into the central nervous system: the importance of alginate viscosity and related factors. CHEN, Z. P., and MOHR, G., Stereotact. Funct. Neurosurg., 1996, 66 (1-3), 141–146.
  • Microencapsulation of chloroquine diphosphate by Eudragit RS100. NDESENDO, V. M., MEIXNER, W., KORSATKO, W., and KORSATKO, W. B., J. Microencapsul., 1996, 134 (1), 1–8.
  • Microencapsulation reactor scale-up by dimensional analysis. MAA, Y. F., and Hsu, C., J. Microencapsul., 1996, 13 (1), 53–66.
  • Microsphere distribution in the pancreas of anaesthetized rats. Alloxan stimulates the blood flow to all islets whereas glucose only affects the blood perfusion of a subgroup of islets. JANSSON, L., Int. J. Pancreatol., 1996, 20 (1), 69–74.
  • Microsphere embolism-induced changes in presynaptic function of the cerebral cortex in rats. HAYASHI, H., TAKAGI, N., KAMIMOTO, N., and TAKEO, S., Brain Res., 1996, 737 (1-2), 64–70.
  • Modeling fluorescence collection from single molecules in microspheres: effects of position, orientation, and frequency. HILL, S. C., SALEHEEN, H. I., BARNES, M. D., WHITTEN, W. B., and RAMSEY, J. M., Appl. Opt., 1996, 35 (31), 6278–6288.
  • Modulation of protein release from chitosan-alginate microcapsules using the pH-sensitive polymer hydroxypropyl methylcellulose acetate succinate. OKHAMAFE, A. 0., AMSDEN, B., CHU, W., and GOOSEN, M. F., J. Microencapsul., 1996, 13 (5), 497–508.
  • Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. DIMATTeo, M., and REASOR, M. J., Toxicol. Appl. Pharmacol., 1997, 142 (2), 411–421.
  • Molecular recognition and colorimetric detection of cholera toxin by polymerized liposomes. PAN, J. J., CHARYCH, D., Langmuir, 1997, 13 (6), 1365–1367.
  • Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages. DE HAAN, A., GROEN, G., PROP, J., VAN ROOIJEN, N., and WILSCHUT, J., Immunology, 1996, 89 (4), 488–493.
  • Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glu-tathione S-transferase. IVANOFF, N., PHILLIPS, N., SCHACHT, A. M., HEYDARI, C., CAPRON, A., and RIVEAU, G., Vaccine, 1996, 14(12), 1123–1131.
  • New formulation of 5-fluorouracil in microspheres reduces toxicity in mice. HAGIWARA, A., SAKAKURA, C., TSUJIMOTO, H., OHGAKI, M., IMANISHI, T., YAMAZAKI, J., SAWAI, K., TAKAHASHI, T., YAMAMOTO, A., MURANISHI, S., TABATA, Y., and IKADA, Y., Anticancer Drugs., 1996, 7 (7), 780–784.
  • Nitronyl nitroxides as NO scavengers and a novel quantitative assay for NO using liposome-incorporated nitronyl nitroxides. AKAIKE, T., Kikan Kagaku Sosetsu, 1996, 30, 63–70.
  • Novel procedure for monodispersed polymeric microspheres with high electrifying additive content by particle-shrinking method via SPG membrane emulsification. YOSHIZAWA, H., OHTA, H., MARUTA, M., UEMURA, Y., 'mut, K., HATATA, Y.,. Chem. Eng. jpn., 1996, 29 (6), 1027–1029.
  • Novel vaginal delivery systems for calcitonin. II. Preparation and characterization of HYAFF microspheres containing calcitonin. ROCHIRA, M., ROSARIA, M. M., RICHARDSON, J. L., FERRARI, L., BECCARO, M., and BENEDETTI L., Int. J. Pharm., 1996, 144 (1), 19–26.
  • On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres. FORSBERG, F., GOLDBERG, B. B., Liu, J. B., MERTON, D. A., and RAWOOL, N. M., J. Ultrasound Med., 1996, 15 (12), 853–860; quiz 861–862.
  • Opioid receptor affinity of multivalent ligand system consisting of polymerized liposome. TETSUI, S., ZHAO, J., KIMURA, S., and IMANISHI, Y., Int. J. Pept. Protein Res., 1996, 48 (1), 95–101.
  • Optimization of the formulation design of chitosan microspheres containing cisplatin. WANG, Y. M., SATO, H., ADACHI, I., and HORIKOSHI,Pharm. Sci., 1996, 85 (11), 1204–1210.
  • Oral administration of recombinant human erythropoietin in liposomes in rats: influence of lipid composition and size of liposomes on bioavailability, MAITANI, Y., HAZAMA, M., TOJO, Y., SHIMODA, N., and NAGAI, T., J. Pharm. Sci., 1996, 85 (4), 440–445.
  • Oral immunization of rabbits against Pasteurella multocida with an alginate microsphere delivery system. SUCKOW, M. A., BOWERSOCK, T. L., PARK, H., and PARK, K., J. Biomater. Sci., Polym. Ed., 1996, 8 (2), 131–139.
  • Oxidative stability of liposomes made from soya lecithin. Mojovic, L. V., SLAVICA, V., SILER, M., and ZAHARIJEV, J. R., Hem. Ind., 1996, 50 (12), 531–536.
  • Performance and preparation of ferromgnetic RFP (rifampin) microspheres. Li, H., and FANG, L., Wuhan Gongye Daxue Xuebao, 1996, 18 (3), 51–53.
  • Permeability changes caused by surfactants in liposomes that model the stratum corneum lipid composition. DE LA MAZA, A., CODERCH, L., LOPEZ, 0., BAUCELLS, J., and PARRA, J. L., J. Am. Oil Chem. Soc., 1997, 74 (1), 1–8.
  • Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate. OKADA, H., DOKEN, Y., OGAWA, Y., J. Pharm. Sci., 1996, 85 (10), 1044–1048.
  • Pesticide and model drug release from carboxymethylcelullose microspheres. DARVARI, R., HASIRCI, V., J. Microencapsul., 1996, 13 (1), 9–24.
  • pH-dependent microspheres from modified soybean protein hydrolysate. MILSTEIN, S. J., BARANTSEVITCH, E. N., GRECHANOVSKI, V. A., and SARUBBI, D. .1., J. Microencapsul., 1996, 13 (6), 651–665.
  • pH-responsive release from polypeptide microcapsules. KIDCHOB, T., KIMURA, S., and IMANISHI, Y., J. Appl. Polym. Sci., 1997, 63 (4), 453–458.
  • Pharmacokinetic rationale for chemotherapeutic drugs combined with intra-arterial degradable starch microspheres (Spherex). JOHANSSON, C. J., Clin. Pharmacokinet, 1996, 31 (3), 231–240. 44 refs.
  • Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice. SATO, H., WANG, Y. M., ADACHI, I., and HORIKOSHI, I., Biol. Pharm. Bull., 1996, 19 (12), 1596–1601.
  • Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCI). WORKING, P. K., and DAYAN, A. D., Hum. Exp. Toxicol., 1966, 15 (9), 751–785. 68 Refs.
  • Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma. GIFtARD, P. M., BOUCHAUD, 0., GOETSCHEL, A., MUKWAYA, G., EESTERMANS, G., Ross, M., ROZENBAUM, W., and SAIMOT, A. G., AIDS, 1996, 10 (7), 753–727.
  • Phospholipid cylindrical liposomes (tubules). NOUNESIS, G., Chem. Chron., Genike Ekdose, 1996, 58 (12), 650–653.
  • Physical stability of teniposide in bile salt-egg phosphatidylcholine mixed micelles and liposomes. SON, K., and AL/CAN, 0. K., PDA J. Pharm. Sci. Technol., 1996, 50 (2), 89–93.
  • Physico-chemical characterization and application for drug carrier of soybean-derived sterols and their glucosides-containing liposomes. MAITANI, Y., 1996, Yakugaku Zasshi, 1996, 116 (12), 901–910.
  • Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. XING, D. K. L., CRANE, D. T., BOLGIANO, B., CORBEL, M. J., JONES, C., and SESARDIC, D., Vaccine, 1996, 14 (13), 1205–1213.
  • Physicochemical properties and application of liposomes with soybean-derived sterols and their glucosides for drug carriers. MAITANI, Y., Hoshi Yakka Daigaku Kiyo, 1996, 38,19–27.
  • Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice. CHANG, C. W., BARBER, L., OUYANG, C., MASIN, D., BALLY, M. B., and MADDEN, T. D., Br. y. Cancer, 1997, 75 (2), 169–177.
  • Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. WASAN, E. K., REIMER, D. L., and BALLY, M. B., y. Pharm. Sci., 1996, 85 (4), 427–433.
  • Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosofisation. CROOK, K., MCLACHLAN, G., STEVENSON, B. J., and PORTEOUS, D. J., Gene Ther., 1996, 3 (9), 834–839.
  • Plumbagin-loaded PLGA microspheres with reduced toxicity and enhanced antitumor efficacy in mice. SINGH, U. V., BISHT, K. S., RAO, S., UMA, D. P., and UDUPA, N., Pharm. Sci., 1996, 2 (9), 407–409.
  • Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines. ERTL, H. C., VARGA, I., XIANG, Z. Q., KAISER, K., STEPHENS, L., and OTVOS, L. JR., Vaccine, 1996, 14(9), 879–850.
  • Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. ZALIPSKY, S., MULLAH, N., HARDING, J. A., GirrELmaN, J., Guo, L., and DEFREES, S. A., Bioconjugate Chem., 1997, 8 (2), 111–118.
  • Poly(ethylene glycol) amphiphile adsorption and liposome partition. VAN ALSTINE, J. M., MALMSTEN, M., BROOKS, D. E., J. Chromatogr. B. Biomed. Appl., 1996, 680 (1–2), 145–155.
  • Polyelectrolyte complexes of sodium alginate with chitosan or its derivatives for microcapsules. LEE, K. Y., PARK, W. H., and HA, W. S., 5. Appl. Polym. Sci., 1997, 63 (4), 425–432.
  • Polyepichlorohydrin stabilized core shell microspheres by dispersion polymerization. LAUS, M., LELLI, M., and CASAGRANDE, A., 5. Polym. Sci., Part A: Polym. Chem., 1997, 35 (4), 681–688.
  • Polymerizable liposomes. III. Synthesis of new kind of liposomes of amphiphilic amino acid. HE, W., Li, Z., and Li, F., Gaofenzi Xuebao, 1996, (5), 615–618.
  • Polymerization in thin layers—monolayers, bilayers, multilayers, and liposomes. FABIA NOWSKI, W., Polimery (Warsaw), 1997, 42 (1), 1–9.
  • Possibilities of application of liposomes for the modification of cheese ripening. SIENKIEWICZ, T., and GEBHARDT, U., Lebensmittelind Milchwirtsch, 1996, 117 (24), 1167–1175.
  • Potentials of liposomes in diagnosis and treatment of pulmonary metastases: an experi-mental study in the rat. ROVEDA, L., PRAT, U., DIOMEDE, L., SALMONA, M., BOTTIROLI, G., ScoRRErra, N., and NAZAR', S., Eur. 5. Cardiothorac. Surg., 1996, 10 (7), 574–578.
  • Preliminary observation on percutaneous absorption of liposomal heparin. HUANG, S., YANG, W., Fu, C., Li, X., Tao, Y., and YANG, C., Zhongguo Shenghua Yaowu Zazhi, 1996, 17(1), 8–11.
  • Preliminary study of the therapeutic effect of tetrandrine polyphase liposome on exptl. silicosis. ZENG, Z., YANG, S., Lu, A., Du, Y., and YANG, X., Gongye Weisheng Yu Zhiyebing, 1996, 22 (4), 242–244.
  • Preoperative lymph-node staining with liposomes containing patent blue violet. A clinical case report. PUMP, B., and HIRNLE, P., J. Pharm. Pharmacol., 1996, 48 (7), 699–701.
  • Preparation and evaluation of flurbiprofen microcapsules by emulsification—solvent eva-poration technique. RAO, B. S., and MURTHY, K. V. R., Indian Drugs, 1996, 33 (8), 397–400.
  • Preparation and release properties of biodegradable chitin microcapsules: I. Preparation of 6-mercaptopurine microcapsules by phase separation methods. Mi, F. L., TSENG, Y. C., CHEN, C. I., and SHYU, S. S., y. Microencapsulation, 1997, 14(1), 15–25.
  • Preparation of regenerated chitin microsphere with a high exclusion-limit molecular weight. 'TOYAMA, K., Fujii, T., Kichin, Kitosan Kenkyu, 1995, 1(2), 49–52.
  • Preparation of poly(D, L-lactide) and copoly(lactide-glycolide) microspheres of uniform size. SHIGA, K., MURAMATSU, N., and KONDO, T., J. Pharm. Pharmacol., 1996, 48 (9), 891–895.
  • Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. WANG, Y. M., SATO, H., ADACHI, I., and HORIKOSHI, I., Chem. Pharm. Bull. (Tokyo), 1996, 44 (10), 1935–1940.
  • Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method. UCHIDA, T., YOSHIDA, K., and GOTO, S., y. Microencapsul., 1996, 13 (2), 219–228.
  • Preparation and in-vitro evaluation of nifedipine loaded albumin microspheres cross-linked by different glutaraldehyde concentrations. CHUO, W. H., TSAI, T. R., Hsu, S. H., and CHAM, T. M., Int. J. Pharm., 1996, 144 (2), 241–245.
  • Preparation and characterization of a complex microencapsulated diet for striped bass Morone saxatilis larvae. OZKIZILCIK, S., and CHU, F. L., J. Microencapsul., 1996, 13 (3), 331–343.
  • Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique. MANDAL, T. K., LOPEZ, A. A., ONYEBUEKE, E., and SHEKLETON, M., J. Microencapsul., 1996, 13 (3), 257–267.
  • Preparation of liposome formulations containing immunomodulatory peptides. PANIC°, A., PIGNATELLO, R., CARDILE, V., and PucLisi, G., Pharm. Acta Hely., 1997, 72 (1), 1–10.
  • Preparation of SOD (superoxide dismutase) liposomes by freeze-thaw method. ZHAO, J., WANG, F., ZHOU, L., and YUAN, Q., Zhongguo Yiyao Gongye Zazhi, 1996, 27 (8), 346–349.
  • Preparation of giant liposomes in physiological conditions and their characterization under an optical microscope. AKASHI, K., MIYATA, H., 'Ton, H., and KINOSITA, K. JR., Biophys. y., 1996, 71 (6), 3242–3250.
  • Preparation and properties of alkylphospholipid liposomes: a review. ZEISIG, R., FICHTNER, I., and ARNDT, D., Cell Mol. Biol. Lett., 1996, 1(4), 447–457.
  • Preparation and the tissue distribution of liposomal CPT-11. SADZUKA, Y., HIROTSU, S., MIYAGISIIIMA, A., NOZAWA, Y., and HIROTA, S., Drug Delivery Syst., 1996, 11(6), 419–426.
  • Preparation of polymeric hollow microspheres (hollow microcapsules). Iuctu, K., YOSHIZAW, H., ASHIKARI, T., UEMURA, Y., and HATATE, Y Kagaku Kogaku Ronbunshu, 1997, 23 (1), 125–128.
  • Preparation of propafenone microcapsules. WENG, D., and Liu, B., Zhongguo Yiyuan Yaoxue Zazhi, 1996, 16 (8), 355–356.
  • Preparation, characterization and in vitro drug release of poly-epsilon-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres. GUZMAN, M., MOLPECERES, J., GARCIA, F., and ABERTURAS, M. R., J. Microencapsul., 1996, 13 (1), 25–39.
  • Production of ceramic composites from lightweight microspheres and expanded granulates. DOWER, J. E., Ind. Ceram. Verriere, 1996, 918, 598–600.
  • Progesterone loaded chitosan microspheres effect of triethylene glycol glutarate linked to the chitosan molecule on drug release. ORIENT, I., AIEDEH, K., PONT, C., GIANASI, E., and ZECCHI, V., STP Pharma. Prat., 1996, 6 (6), 424–429.
  • Progress in preparation and application of magnetic polymer microspheres. DING, X., SUN, Z., and WAN, G., Huaxue Tongbao, 1997, (1), 1–6.
  • Prolongation of liposome circulation time by various derivatives of polyethyleneglycols. YUDA, T., MARUYAMA, K., and IWATSURU, M., Biol. Pharm. Bull., 1996, 19 (10), 1347–1351.
  • Prolonged immune response evoked by a single subcutaneous injection of microcapsules having a monophasic antigen release. SAH, H., and CHIEN, Y. W., y. Pharm. Pharmacol., 1996, 48(1), 32–36.
  • Prolonged retention of cross-linked trypsin in calcium alginate microspheres. Cum, W. K., and WAN, L. S. C. J. Microencapsulation, 1997, 14 (1), 51–61.
  • Properties of practical oral liposome-Streptococcus mutans glucosyltransferase vaccines for effective induction of caries protection. CHILDERS, N. K., ZHANG, S. S., HAROKOPAKIS, E. HARMON, C. C., and MICFIALEK, S. M., Oral Microbiol. Immunol., 1996, 11(3), 172–180.
  • Properties of multiphase microspheres of poly(dl-lactic acid) or poly (dl-lactic-co-glycolic acid) produced by mechanical agitation, sonication, or potentiometric dispersion. O'DONNELL, P. B., and MCGINITY, J. w., J. Microencapsul., 1996, 13 (6), 667–677.
  • Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres. ALLAOUI, A. K., PECQUET, S., FATTAL, R., TROLLE, S., CHACHATY, E., COUVREUR, P., and ANDREMONT, A., Infect. Immun., 1997, 65 (3), 853–857.
  • Protective prophylactic immunity against intranasal ricin challenge induced by liposomal ricin A subunit. MATYAS, G. R., and ALVING, C. R., Vaccine Res., 1996, 5 (3), 163–172.
  • Pulmonary targeting of liposomal triamcinolone acetonide phosphate. GONZALEZ, R. R. J., SUAREZ, S., HOCHHAUS, G., SCHREIER, H., LUKYANOV, A., DERENDORE, H., and COSTA, T. D., Pharm. Res., 1996, 13 (11), 1699–1703.
  • Quadrupole radiation of an atom in the vicinity of a dielectric microsphere. K 'Amoy, V. V., and LETOKHOV, V. S., Phys. Rev. A: At, Mol., Opt. Phys., 1996, 54 (5), 4408–4423.
  • Reactivity of mammalian 15-lipoxygenase with phospholipids in large unilamellar liposomes. ARAI, H., SUZUKI, T., TAKAMA, K., and TERAO, J., Biochem. Biophys. Res. Commun., 1996, 228 (3), 675–682.
  • Release of pharmaceuticals from microcapsules prepared with polymers of amino acids or lactic acid. IMANISHI, Y., and KIMURA, S., Kyoto Daigaku Nippon Kagaku Sen'i Kenkyusho Koenshu, 1996, 53, 15–21.
  • Research on the adsorptive properties of starch microsphere. Yu, J., and Liu, Y., Liz,' jiaohuan Yu Xifu, 1996, 12 (2), 124–128.
  • Retinoic acid liposomes: preparation and evaluation. LEUCUTA, S. E., POPOVICI, M., Rusu, A., and PORUTIU, D., Farmacia (Bucharest), 1996, 44 (5-6), 76–83.
  • Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation. SORACE, J. M., ROLLINS, S., ANIAGOLU, J. U., MERGNER, W. J., Coi.E, K., SWARTZ, G. M., JR.,GREEN, S. J., Pathobiology, 1996, 64 (2), 73–87.
  • Role of macrophages in the candidacidal activity of liposomal amphotericin B. MEHTA, R. T., PODDAR, S., KALIDAS, M., GOMEZ, F. R., and DULSKI, K., y. Infect. Dist., 1997, 175(1), 214–217.
  • Short-course tratment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). DAVIDSON, R. N., DI MARTINO, L., GRADONI, L., GIACCIIINO, R., GAETA, G. B., PENIPINELLO, R., Scum'', S., CASCIO, A., CASTAGNOLA, E., MAISTO, A., GRAMICCIA, M., DI CAPRIO, D., WILKINSON, R. J., and BRYCESON, A. D., Clin. Infect. Dis., 1996, 22 (6), 938–943.
  • Simultaneous determination of carbamazepine and its metabolites in plasma from carbon tetrachloride-intoxicated rats using a new reversed-phase chromatographic column of 2-pm porous microspherical silica gel. TANAKA, E., J. Chromatogr., B: Blamed. Appl., 1997, 688(1), 155–160.
  • Simultaneous determination of twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-microns porous microspherical silica gel. TANAKA, E., TEWRADA, M., MISAWA, S., and WAKAstica,Chromatogr. B. Blamed. Appl.,1996, 682 (1), 173–178.
  • Size effect on the antibody production induced by biodegradable microspheres containing antigen. NAKAOKA, R., INca_JE, Y., TABATA, Y., and IKADA, Y., Vaccine, 1996, 14(13), 1251–1256.
  • Size disttribution characteristics and entrapment efficiency of dried-reconstituted liposomes containing epidermal growth factor. Kim, H. J., Yu, S. U., Clio', Y. W., Yakhak Hoechi, 1996, 40(6), 646–652.
  • Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma. FEaDous, A. J., swim, T., SHINOHARA, M., HARASHINIA, H., and KiwAnA, H., Biopharm. Drug. Dispos., 1996, 17(2), 145–154.
  • Slow delivery of the selective cholecystrokinin agonist pBC 264 into the rat nucleus accumbens using microspheres. BI.ANCO, P. M. J., Dull tEux, C., DAUGE, V., FATTAL, E., Couvanua, P., RoQuEs, B. P., 1. Neurochem., 1996, 67 (6), 2417–2424.
  • Solid tumor chemotherapy using injectable gelatin microspheres containing free metho-trexate and conjugated methotrexate. NARAYANI, R., and PANDURANGA, R. K., Int. J. Pharm., 1996, 142 (1), 25–32.
  • Solvent and plasticizer influences on ethylcellulose-microcapsules. PALOMO, NI. E., BALLEsmitos, NI. P., and Fau-ros, P., J. Microencapsul., 1996, 13 (3), 307–318.
  • Sonochemical deposition and characterization of nanophasic amorphous nickel on silica microspheres. RAmEsi 1, S., KOLTYPIN, Y., PanzoRov, R., and GEDANKEN, A., Chem. Mater., 1997, 9 (2), 546–551.
  • Specific inhibitory effect of hybrid liposomes on the growth of hybridoma cells in vitro. IMAMURA, C., KANNO, A., MITSUOKA, C. KITAHMA, S., INOUE, H., IWAHARA, M., MATSUMOTO, Y., UEOKA, R., Yakugaku Zasshi, 1996, 116 (12), 942–950.
  • Spermidine-condensed DNA and cone-shaped lipids improve delivery and expression of exogenous DNA transfer by liposomes. IBANEZ, M., GARIGLIO, P., CHAVEZ, P., SANTIAGO, R., WONG, C., and BAEZA, I., Biochem. Cell Biol., 1996, 74 (5), 633–643.
  • Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. HONG, K., ZHENG, W., BAKER, A., and PAPAHADJOPOULOS, D., FEBS Lett., 1997, 400 (2), 233–237.
  • Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents, and prolonged circulation in vivo. SLEPUSHKIN, V. A., SIMOES, S., DAZIN, P., NEWMAN, M. S., Guo, L. S., PEDROSO DE LIMA, M., and DUZGUNES, N., J. Biol. Chem., 1997, 272 (4), 2382–2388.
  • Structural characteristics of cationic liposomes with potent enhancing effect on retroviral transduction into human hepatoma cells. KANEKO, Y., and TsuKAmo-ro, A., Cancer Lett. (Shannon, Irel), 1996, 107 (2), 211–215.
  • Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar mem-branes in distinct interhelical packing regimes (see comments). RADLER, J. 0., KOLTOVER, I., SALorr-r, T., and SAFINYA, C. R., Science, 1997, 275 (5301), 810–814.
  • Studies of succinate dehydrogenase inhibition (SDI) test with cisplatin encapsulated lipo-some against cancer cells. KOKETSU, M., SUZUKI, K., YOTSUYANAGI, T., and BABA, S., Acta Otolaryngol. Suppl. ( Stockh ), 1996, 525, 120–124.
  • Studies on preparation and characteristics of cisplatin chitosan microsphers. WANG, Y., SHI, T., Pu, Y., ZHU, J., and ZHAO, Y Yaoxue Xuebao, 1996, 31(4), 300–305.
  • Studies on the formulation and in vitro release of ophthalmic liposomes containing dex-amethasone sodium phosphate. AL MUHAMMAD, J., OZER, A. Y., and HINCAL, A. A., .7. Microencapsul., 1996, 13 (2), 123–130.
  • Studies on the preparation of cisplatin chitosan microspheres. WANG, Y., and SHII, T., junshi Yixue Kexueyuan Yuankan, 1996, 20 (3), 195–198.
  • Study of choroidal blood flow by comparison of SLO fluorescein angiography and microspheres. DUIJM, H. F., RULO, A. H. F., ASTINS, M., MAEPEA, 0., VAN DENBERG, T. J. T. P., and GREVE, E. L., Exp. Eye Res., 1996, 63 (6), 693–704.
  • Study on HPLC assay for the plasma concentration of rifampicin and its pharmacokinetics of microsphere formulation. ZHANG, W., JIANG, X., and ZHU, C., Zhongguo Kangshengsu Zazhi, 1996, 21(4), 273–276.
  • Study on the mitoxantrone ethyl cellulose microsphere for liver artery embolization. ZHANG, Z., WANG, D., LIAO, F., and LIAO, G., Yaoxue Xuebao, 1996, 31(8), 626–631.
  • Study on effect of liposome-EDTA on SOD activity in mice intoxicated with HgC12. Du, J., WANG, K., YANG, H., Li, Z., and BI, X., Gongye Weisheng Yu Zhiyebing, 1996, 22(3), 136–138.
  • Study on in vitro stability of polymerized liposomes. NISFIIYA, T., and JAN, B., Artif. Cells Blood Substit. Immobil. Biotechnol., 1996, 24 (1), 43–50.
  • Sublytic interactions of octylphenol surfactants with liposomes modeling the stratum corneum lipid composition. DE LA MAZA, A., BAUCELLS, J., ENsENAT, P. G., and PARRA, J. L..7. Colloid Interface Sci., 1996, 184 (1), 155–162.
  • Surface characterization of poly(alpha-hydroxy acid) microspheres prepared by a solvent evaporation/extraction process. BOURY, F., MARCHAIS, H., BENOIT, J. P., and PROUST, J. E., Biomaterials, 1997, 18 (2), 125–136.
  • Sustained tissue drug concentration following inhalation of liposome encapsulated fentanyl in rabbits. TAN, S., HUNG, 0., WHYNOT, S., and MEZEI, M., Drug Delivery, 1996, 3 (4), 251–254.
  • Syncytium formation enables fusion of naked liposomes to cells. SHIMA, V., Osaka Daigaku Igaku Zasshi, 1996, 48 (6-12), 319–329.
  • Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats. HARASHIMA, H., HUONG, T. M., ISHIDA, T., MANABE, Y., MATSUO, H., and KIWADA, H., Pharm. Res., 1996, 13(11), 1704–1709.
  • Synthesis of short polyoxyethylene-based heterobifunctional cross-linking reagents. Applica-tion to the coupling of peptides to liposomes. FRISCH, B., BOECKLER, C., and SCHUBER, F., Bioconjug. Chem., 1996, 7(2), 180–186.
  • Synthesis, lipophilic derivatization and interaction wth liposomes of HAV-VP3 (102-121) sequence by using spectroscopic techniques. GARCIA, H., PUJOL, M., REIG, F., ALSINA, M. A., and HARO, I., Analyst (Cambridge, U.K.), 1996, 121 (11), 1583–1588.
  • Synthetic cationic amphiphile for liposome-mediated DNA transfection with less cytotoxicity. KATO, T., 1wAmoTo, K., ANDO, H., ASAKAWA, N., TANAKA, I., KIKUCHI, J., MURAKAMI, Y., Biol. Pharm. Bull., 1996, 19 (6), 860–863.
  • Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. GOREN, D., HOROWITZ, A. T., ZALIPSKY, S., WOODLE, M. C., YARDEN, Y., and GABIZON, A., Br. .7. Cancer, 1996, 74 (11), 1749–1756.
  • The importance of standardization of carboxymethylchitin concentration by the dye-binding capacity of alcian blue before adsorption on liposomes. MOBED, M., ENG, M., CHANG, T. M., Arta* f. Cells Blood Substiut. Immobil. Biotechnol., 1996, 24 (2), 107–120.
  • Thje role of helper lipids in cationic liposome-mediated gene transfer. Hui, S. W., LANGNER, M., ZHAO, Y. L., Ross, P., HURLEY, E., and CHAN, K., Biophys. .7., 1996, 71(2), 590–599.
  • The effect of adriamycin against a liver metastatic model by encapsulation in liposomes. YACHI, K., SUZUKI, N., TANAKA, N., OKADA, K., MITSUI, I. KAWATO, Y KOMAGATA, Y., KOMIYAMA, K., and KIKUCHI, H., Biopharm. Drug Dispos., 1996, 17 (8), 699–715.
  • The effect of lipid molecular packing stress on cationic liposome-induced rabbit erythrocyte fusion. Li, L. H., and Hui, S. W., Biochim. Biophys. Acta, 1997, 1323 (I), 105–116.
  • The incorporation and release of bovine serum albumin from poly-hydroxybutyrate-hydroxyvalerate microcapsules. ATKINS, T. W., and PEACOCK, J., J. Microencapsul., 1996, 13 (6), 709–717.
  • The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig's eye. LIN, H. H., Ko, S. M., Hsu, L. R., and TSAI, Y. H., J. Pharm. Pharmacol., 1996, 48 (8), 801–805.
  • The pulmonary uptake of intravenously administered liposomal alpha-tocopherol is aug-mented in acute lung injury. SUNTRES, Z. E., and SHEK, P. N., J. Drug Target, 1996, 4 (3), 151–159.
  • The study of immunological response to long-term release system hCG microsphere in C57 black mice. DU-XIAOYAN, WANG-JIAN, XU-KANGJIE, JIANG-HONGLIANG, LIU-SHIFAN., SHENGZHI Yu BIYUN, 1996, 16 (4), 254–258. 285.
  • The use of cationic liposomes DC-CHOL/DOPE and DDAB/DIOE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors. SZALA, S., MISSOL, E., SOCHANIK, A., and STROZYK, M., Gene Ther., 1996, 3 (11), 1026–1031.
  • The effect of vincristine-polyanion complexes in STEALTH liposomes on pharmacokinetics, toxicity and anti tumor activity. ZHU, G., OTO, E., VAAGE, J., QUINN, V., NEWMAN, M., ENGBERS, C., and USTER, P., Cancer Chemother. Pharmacol., 1996, 39 (1-2), 138–142.
  • The pulmonary uptake of intravenously administered liposomal alpha-tocopherol is aug-mented in acute lung injury. SUNTRES, Z. E., and SHER, P. N., J. Drug Targeting, 1996, 4 (3), 151–159.
  • The stability of liposomes to ultrasonic nebulization. LEUNG, K. K. M., BRIDGES, P. A., and TAYLOR, K. M. G., Int. y. Pharm., 1996, 145 (1, 2), 95–102.
  • The structure of DNA-liposorne complexes. LASIC, D. D., STREY, H., STUART, M. C. A., PODGORNIK, R., and FREDERIK, P. m., J. Am. Chem. Soc., 1997, 119 (4), 832–833.
  • Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection. KANSAL, R. G., GOMEZ, F. R., SINHA, I., and MEHTA, R. T., Antimicrob. Agents Chemother., 1997, 41(1), 17–23.
  • Therapeutic opportunities for targeted liposomal drug delivery. ALLEN, T. M., and MOASE, E. H., Adv. Drug Delivery Rev., 1996, 21 (2), 117–133.
  • Thermally insulating and radiotransparent ceramics from aluminosilicate microspheres. AKSEL, L. M., GORYACFIEVA, Z. E., CHUPRINA, N. A., Kizn., L. Y., and SHPITSGLUZ, A. L., Ogneupory Tekh Keram, 1996, (10), 5–9.
  • Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. GAYER, M. H., Wu, N. Z., HONG, K., HUANG, S. K., DEWHIRST, M. W. and PAPAHADJOPOULOS, D., Int. J. Radial. Oncol., Biol., Phys., 1996, 36 (5), 1177–1187.
  • TLC characterization of small unilamellar liposomes containing D-myo-inositol derivatives. BRAILOIU, E., BESCHEA, C., BRAILOW, C., COSTULEANU, A., FILIPEANU, C. M., COSTULEANU, M., FALLGFREN, B., and BRANISTEANU, D. D., Biomed. Chromatogr., 1996, 10 (5), 233–236.
  • Topical penetration of tretinoin in vitro from liposomal gel and its stability. XUE, Y., ZHAO, J., WENG, G., Liu, Y., and Su, M., Zhongguo Yaoke Daxue Xuebao, 1996, 27 (7), 405-407. Topical liposome delivery of molecules to hair follicles in mice. Li, L., and HOFFMAN, R., J. Dermatol. Sci., 1997, 14 (2), 101–108.
  • Toxicity of doxorubicin entrapped within long-circulation liposomes. DAEMEN, T., REGTS, J., MEESTERS, M., TEN, K. M. T., BAKKER-WOUDENBERG, I. A. J. M., and Scherphof, G. L., J. Controlled Release, 1997, 44 (1), 1–9.
  • Transcytosis of lipid microspheres by human endothelial cells. TAKAHASHI, K., SUZUKI, K., ICHIKI, Y., FUKUSHIMA, T., NAKAMURA, H., and SAWASAKI Y., Pharmacology, 1996, 53(1), 37–47.
  • Transdermal iontophoretic delivery of colchicine encapsulated in liposomes. KULKARNI, S. B., BANGA, A. K., and BETAGERI, G. V., Drug Delivery, 1996, 3 (4), 245–250.
  • Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. CEVC. G., Crit. Rev. They. Drug Carrier Syst., 1996, 13 (3–4), 257–388. 331 Refs.
  • Transient laser heating of single solid microspheres. Foss, W. R., and DAVIS, E. J., Chem. Eng. Commun., 1996, 152–153. 113–138.
  • Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin. DUZGUNECS, N., FLASHER, D., REDDY, M. V., LUNA, H. J., and GANGADHARAM, P. R., Antimicrob. Agents Chemother., 1996, 40 (11), 2618–2126.
  • Treatment of massive hemorrhage with liposome encapsulated human hemoglobin (NRC) and hydroxyethyl starch (HES) in beagles. TAKAORI, M. and FUKUI, A., Anil Cells Blood Substit. Immobil. Biotechnol., 1996, 24 (6), 643–653.
  • Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation. LAURENT, A., BEAUJEUX, R., WASSEF, M., RUFENACHT, D., BOSCHETTI, E., and MERI.AND, J, J., AYNR Am, J. Neuroradiol., 1996, 17 (3), 533–540.
  • Trisacryl gelatin microspheres for therapeutic embolization, II: preliminary clinical evalua-tion in tumors and arteriovenous malformations. BEAUJEUX, R., LAURENT, A., WASSEF, M., CASASCO, A., GOBIN, Y. P., AYMARD, A., RUFENACHT, D., and MERLAND, J. J., AYNR-Am-Y-Neuroradiol., 1996, 17 (3), 541–548.
  • Tumour uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma. VAAGE, J., DONOVAN, D., USTER, P., and WORKING, P. 0., Br. J. Cancer, 1997, 75 (4), 482–486.
  • Two-dimensional microsphere quasi-crystal: fabrication and properties. NOGINOVA, N., VENKATESWARLU, P., SARKISOV, S., NOGINOV, M. A., CAULFIELD, H. J., and CURLEY, M., Proc. SPIE Int. Soc. Opt. Eng., 1996, 2824, 36–45.
  • Uptake of archaebacterial liposomes and conventional liposomes by phagocytic cells. TOLSON, D. L., LATTA, R. K., PATEL, G. B., and SPROTT, G. D., y. Liposome Res., 1996, 6 (4), 755–776.
  • Use of an enzyme immunoassay for the evaluation of entrapment efficiency and in vitro stability in intestinal fluids of liposornal bovine serum albumin. RAMALDES, G. A., DEVERRE, J. R., GROGNET, J. M., PUISIEUZ, F., and FATTAL, E., int. J. Pharm., 1996, 143 (1), 1–11.
  • Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells. KAO, G. Y., CHANGE, L. J., and ALLEN, T. M., Cancer Gene. Ther., 1996, 3 (4), 250–256.
  • Zeaxanthin (dihydroxy-beta-carotene) but not beta-carotene rigidifies lipid membranes: a 1H-NMR study of carotenoid-egg phosphatidylcholine liposomes. GABRIELSKA, J., and GRUSZECKI, W. I., Biochim. Biophys. Acta, 1996, 1285 (2), 167–174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.